{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 507238, "items": [{"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T05:48:55Z", "timestamp": 1574315335160}, "publisher-location": "Basel", "reference-count": 0, "publisher": "KARGER", "isbn-type": [{"value": "3805582161", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2007]]}, "DOI": "10.1159/000107090", "type": "book-chapter", "created": {"date-parts": [[2007, 8, 8]], "date-time": "2007-08-08T15:14:13Z", "timestamp": 1186586053000}, "page": "140-145", "source": "Crossref", "is-referenced-by-count": 12, "title": ["Genetic Polymorphisms in Folate- Metabolizing Enzymes and Risk of Gastroesophageal Cancers: A Potential Nutrient-Gene Interaction in Cancer Development"], "prefix": "10.1159", "author": [{"given": "Dongxin", "family": "Lin", "sequence": "first", "affiliation": []}, {"given": "Hui", "family": "Li", "sequence": "additional", "affiliation": []}, {"given": "Wen", "family": "Tan", "sequence": "additional", "affiliation": []}, {"given": "Xiaoping", "family": "Miao", "sequence": "additional", "affiliation": []}, {"given": "Li", "family": "Wang", "sequence": "additional", "affiliation": []}], "member": "127", "container-title": ["Nutrigenomics - Opportunities in Asia", "Forum of Nutrition"], "link": [{"URL": "http://www.karger.com/Article/Pdf/107090", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 10, 25]], "date-time": "2017-10-25T17:28:25Z", "timestamp": 1508952505000}, "score": 87.15399, "issued": {"date-parts": [[2007]]}, "ISBN": ["3805582161"], "references-count": 0, "URL": "http://dx.doi.org/10.1159/000107090"}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T07:10:17Z", "timestamp": 1574493017610}, "publisher-location": "Berlin, Heidelberg", "reference-count": 19, "publisher": "Springer Berlin Heidelberg", "isbn-type": [{"value": "9783642744327", "type": "print"}, {"value": "9783642744303", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1989]]}, "DOI": "10.1007/978-3-642-74430-3_15", "type": "book-chapter", "created": {"date-parts": [[2012, 7, 28]], "date-time": "2012-07-28T23:36:17Z", "timestamp": 1343518577000}, "page": "141-147", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Genetic Polymorphisms of Drug-Metabolizing Enzymes: Molecular Mechanisms"], "prefix": "10.1007", "author": [{"given": "U. A.", "family": "Meyer", "sequence": "first", "affiliation": []}, {"given": "U.", "family": "Zanger", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Skoda", "sequence": "additional", "affiliation": []}, {"given": "D. M.", "family": "Grant", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "15_CR1", "doi-asserted-by": "publisher", "first-page": "551", "DOI": "10.1073/pnas.84.2.551", "volume": "84", "author": "P Beaune", "year": "1987", "unstructured": "Beaune P, Dansette PM, Mansuy D, Kiffel L, Finck M, Amar C, Leroux JP, Homberg JC (1987) Human anti-endoplasmic reticulum autoantibodies appearing in a drag-induced hepatitis are directed against a human liver cytochrome P450 that hydroxylates the drug. Proc Natl Acad Sci USA 84: 551\u2013555", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "15_CR2", "doi-asserted-by": "publisher", "first-page": "4145", "DOI": "10.1016/0006-2952(87)90573-9", "volume": "36", "author": "P Dayer", "year": "1987", "unstructured": "Dayer P, Kronbach T, Eichelbaum M, Meyer UA (1987) Enzymatic basis of the debriso- quine/sparteine-type genetic polymorphism of drug oxidation. Biochem Pharmacol 36: 4145\u20134152", "journal-title": "Biochem Pharmacol"}, {"key": "15_CR3", "first-page": "2298", "volume": "43", "author": "M Eichelbaum", "year": "1984", "unstructured": "Eichelbaum M (1984) Polymorphic drug oxidation in humans. Fed Proc 43: 2298\u20132302", "journal-title": "Fed Proc"}, {"key": "15_CR4", "doi-asserted-by": "crossref", "first-page": "455", "DOI": "10.1111/j.1365-2125.1987.tb03075.x", "volume": "23", "author": "M Eichelbaum", "year": "1987", "unstructured": "Eichelbaum M, Baur MP, Dengler HJ, Osikowska-Evers BO, Tieves G, Zekorn C, Rittner C (1987) Chromosomal assignment of human cytochrome P-450 (debrisoquine/sparteine type) to chromosome 22. Br J Clin Pharmacol 23: 455", "journal-title": "Br J Clin Pharmacol"}, {"key": "15_CR5", "doi-asserted-by": "publisher", "first-page": "442", "DOI": "10.1038/331442a0", "volume": "331", "author": "FJ Gonzalez", "year": "1988", "unstructured": "Gonzalez FJ, Skoda RC, Kimura S, Umeno M, Zanger UM, Nebert DW, Gelboin HV, et al. (1988) Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. Nature 331: 442\u2013446", "journal-title": "Nature"}, {"key": "15_CR6", "doi-asserted-by": "crossref", "first-page": "459", "DOI": "10.1111/j.1365-2125.1984.tb02372.x", "volume": "17", "author": "DM Grant", "year": "1984", "unstructured": "Grant DM, Tang BK, Kalow W (1984) A simple test for acetylator phenotype using caffeine. Br J Clin Pharmacol 17: 459\u2013464", "journal-title": "Br J Clin Pharmacol"}, {"key": "15_CR7", "unstructured": "Gut J, Catin T, Dayer P, Kronbach T, Zanger U, Meyer UA (1986 a) Debriso- quine/sparteine-type polymorphism of drug oxidation: purification and characterization of two functionally different human liver cytochrome P450 isozymes involved in impaired hydroxylation of the prototype substrate bufuralol. J Biol Chem 261: 1 1734"}, {"key": "15_CR8", "doi-asserted-by": "crossref", "first-page": "435", "DOI": "10.1016/0304-4165(86)90194-7", "volume": "884", "author": "J Gut", "year": "1986", "unstructured": "Gut J, Meier UT, Catin T, Mayer UA (1986 b) Mephenytoin-type polymorphism of drug oxidation: purification and characterization of a human liver cytochrome P-450 isozyme catalyzing microsomal mephenytoin hydroxylation. Biochim Biophys Acta 884: 435\u2013447", "journal-title": "Biochim Biophys Acta"}, {"key": "15_CR9", "doi-asserted-by": "publisher", "first-page": "646", "DOI": "10.1038/clpt.1986.113", "volume": "39", "author": "E Jacqz", "year": "1986", "unstructured": "Jacqz E, Hall SD, Branch RA, Wilkinson GR (1986) Polymorphic metabolism of mephenytoin in man. Pharmacokinetic interaction with a co-regulated substrate, mephobarbital. Clin Pharmacol Ther 39: 646\u2013653", "journal-title": "Clin Pharmacol Ther"}, {"key": "15_CR10", "doi-asserted-by": "publisher", "first-page": "24", "DOI": "10.1016/0003-2697(87)90006-6", "volume": "162", "author": "T Kronbach", "year": "1987", "unstructured": "Kronbach T, Mathys D, Gut J, Catin T, Meyer UA (1987) High performance liquid chromatographic assays for bufuralol l\u2019-hydroxylase, debrisoquine 4-hydroxylase, and dextromethorphan O-demethylase in microsomes and purified cytochrome P-450 isozymes of human liver. Anal Biochem 162: 24\u201332", "journal-title": "Anal Biochem"}, {"key": "15_CR11", "doi-asserted-by": "publisher", "first-page": "341", "DOI": "10.1055/s-2008-1040786", "volume": "3", "author": "A K\u00fcpfer", "year": "1983", "unstructured": "K\u00fcpfer A, Preisig R (1983) Inherited defects of hepatic drug metabolism. Semin Liver Dis 3: 341\u2013354", "journal-title": "Semin Liver Dis"}, {"key": "15_CR12", "doi-asserted-by": "publisher", "first-page": "8466", "DOI": "10.1021/bi00399a065", "volume": "26", "author": "UT Meier", "year": "1987", "unstructured": "Meier UT, Meyer UA (1987) Genetic polymorphism of human cytochrome P450 S- mephenytoin-4-hydroxylase. Biochemistry 26: 8466\u20138474", "journal-title": "Biochemistry"}, {"key": "15_CR13", "doi-asserted-by": "publisher", "first-page": "286", "DOI": "10.1016/0003-2697(85)90177-0", "volume": "151", "author": "UT Meier", "year": "1985", "unstructured": "Meier UT, Kronbach T, Meyer UA (1985) Assay of mephenytoin metabolism in human liver microsomes by high-performance liquid chromatography. Anal Biochem 151: 286\u2013291", "journal-title": "Anal Biochem"}, {"key": "15_CR14", "doi-asserted-by": "publisher", "first-page": "488", "DOI": "10.1038/clpt.1985.213", "volume": "38", "author": "UT Meier", "year": "1986", "unstructured": "Meier UT, Dayer P, Male PJ, Kronbach T, Meyer UA (1986) Mephenytoin hydroxylation polymorphism: characterization of the enzymatic deficiency in liver microsomes of poor metabolizers phenotyped in vivo. Clin Pharmacol Ther 38: 488\u2013494", "journal-title": "Clin Pharmacol Ther"}, {"key": "15_CR15", "author": "UA Meyer", "first-page": "95", "year": "1987", "unstructured": "Meyer UA (1987) Polymorphisms of human drug metabolising enzymes. In: Benford DJ, Bridges JW, Gibson GG (eds) Drug metabolism - from molecules to man. Taylor and Francis, London, pp 95\u2013105", "volume-title": "Drug metabolism - from molecules to man"}, {"key": "15_CR16", "doi-asserted-by": "publisher", "first-page": "5240", "DOI": "10.1073/pnas.85.14.5240", "volume": "85", "author": "RC Skoda", "year": "1988", "unstructured": "Skoda RC, Gonzalez FJ, Demierre A, Meyer UA (1988) Two mutant alleles of the human cytochrome P450dbl-gQm associated with genetically deficient metabolism of debrisoquine and other drugs. Proc Natl Acad Sci USA 85: 5240\u20135243", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "15_CR17", "first-page": "25", "volume": "37", "author": "WW Weber", "year": "1985", "unstructured": "Weber WW, Hein DW (1985) N-acetylation pharmacogenetics. Pharmacol Rev 37: 25\u201379", "journal-title": "Pharmacol Rev"}, {"key": "15_CR18", "doi-asserted-by": "crossref", "first-page": "5447", "DOI": "10.1021/bi00415a010", "volume": "27", "author": "UM Zanger", "year": "1988", "unstructured": "Zanger UM, Vilbois F, Hardwick JP, Meyer UA (1988 a) Absence of hepatic cytochrome P450bufl causes genetically deficient debrisoquine oxidation in man. Biochemistry 27: 5447\u20135454", "journal-title": "Biochemistry"}, {"key": "15_CR19", "doi-asserted-by": "crossref", "first-page": "8256", "DOI": "10.1073/pnas.85.21.8256", "volume": "85", "author": "UM Zanger", "year": "1988", "unstructured": "Zanger UM, Hauri HP, Loeper J, Homberg JC, Meyer UA (1988 b) Antibodies against human cytochrome P450dbl in autoimmune hepatitis type II. Proc Natl Acad Sci USA 85: 8256\u20138260", "journal-title": "Proc Natl Acad Sci USA"}], "container-title": ["Clinical Pharmacology in Psychiatry"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-3-642-74430-3_15", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 5]], "date-time": "2019-11-05T02:00:22Z", "timestamp": 1572919222000}, "score": 34.154392, "issued": {"date-parts": [[1989]]}, "ISBN": ["9783642744327", "9783642744303"], "references-count": 19, "URL": "http://dx.doi.org/10.1007/978-3-642-74430-3_15", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T00:11:35Z", "timestamp": 1575159095463}, "reference-count": 1, "publisher": "Wiley", "issue": "45", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 4312, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["ChemInform"], "published-print": {"date-parts": [[2003, 11, 11]]}, "DOI": "10.1002/chin.200345133", "type": "journal-article", "created": {"date-parts": [[2005, 6, 30]], "date-time": "2005-06-30T11:15:21Z", "timestamp": 1120130121000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["7-Methyl Trimethoprim Analogues as Inhibitors of the Folate Metabolizing Enzymes."], "prefix": "10.1002", "volume": "34", "author": [{"given": "Aleem", "family": "Gangjee", "sequence": "first", "affiliation": []}, {"given": "Xin", "family": "Lin", "sequence": "additional", "affiliation": []}, {"given": "Sherry F.", "family": "Queener", "sequence": "additional", "affiliation": []}], "member": "311", "reference": [{"key": "10.1002/chin.200345133-BIB1", "author": "Gangjee", "volume": "40", "first-page": "507", "year": "2003", "journal-title": "J. Heterocycl. Chem.", "DOI": "10.1002/jhet.5570400315", "doi-asserted-by": "crossref"}], "container-title": ["ChemInform"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fchin.200345133", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/chin.200345133", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 3]], "date-time": "2019-03-03T06:29:08Z", "timestamp": 1551594548000}, "score": 32.46344, "issued": {"date-parts": [[2003, 11, 11]]}, "references-count": 1, "journal-issue": {"published-print": {"date-parts": [[2003, 11, 11]]}, "issue": "45"}, "URL": "http://dx.doi.org/10.1002/chin.200345133", "relation": {"cites": []}, "ISSN": ["0931-7597", "1522-2667"], "issn-type": [{"value": "0931-7597", "type": "print"}, {"value": "1522-2667", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T09:09:36Z", "timestamp": 1574154576466}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2003, 5, 1]], "date-time": "2003-05-01T00:00:00Z", "timestamp": 1051747200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Lung Cancer"], "published-print": {"date-parts": [[2003, 5]]}, "DOI": "10.1016/s0169-5002(03)00027-8", "type": "journal-article", "created": {"date-parts": [[2003, 4, 25]], "date-time": "2003-04-25T03:25:55Z", "timestamp": 1051241155000}, "page": "123-129", "source": "Crossref", "is-referenced-by-count": 53, "title": ["Analysis of NQO1, GSTP1, and MnSOD genetic polymorphisms on lung cancer risk in Taiwan"], "prefix": "10.1016", "volume": "40", "author": [{"given": "P", "family": "Lin", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Lung Cancer"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0169-5002(03)00027-8?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0169-5002(03)00027-8?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 3, 27]], "date-time": "2019-03-27T05:27:48Z", "timestamp": 1553664468000}, "score": 32.103497, "issued": {"date-parts": [[2003, 5]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2003, 5]]}, "issue": "2"}, "alternative-id": ["S0169-5002(03)00027-8"], "URL": "http://dx.doi.org/10.1016/s0169-5002(03)00027-8", "ISSN": ["0169-5002"], "issn-type": [{"value": "0169-5002", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 5]], "date-time": "2019-12-05T00:05:42Z", "timestamp": 1575504342950}, "reference-count": 44, "publisher": "Wiley", "issue": "21", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 413, "content-version": "tdm"}], "funder": [{"DOI": "10.13039/100000054", "name": "National Cancer Institute", "doi-asserted-by": "publisher", "award": ["105145", "38926", "46113", "32102", "58882"]}, {"name": "German Cancer Research Center (DKFZ)", "award": ["Postdoctoral Program"]}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer"], "published-print": {"date-parts": [[2014, 11, 1]]}, "DOI": "10.1002/cncr.28830", "type": "journal-article", "created": {"date-parts": [[2014, 7, 15]], "date-time": "2014-07-15T19:52:21Z", "timestamp": 1405453941000}, "page": "3329-3337", "source": "Crossref", "is-referenced-by-count": 9, "title": ["Polymorphisms in folate-metabolizing enzymes and response to 5-fluorouracil among patients with stage II or III rectal cancer (INT-0144; SWOG 9304)"], "prefix": "10.1002", "volume": "120", "author": [{"given": "Cornelia M.", "family": "Ulrich", "sequence": "first", "affiliation": [{"name": "Division of Preventive Oncology; National Center for Tumor Diseases; Heidelberg Germany"}, {"name": "German Cancer Research Center and German Consortium for Translational Cancer Research; Heidelberg Germany"}, {"name": "Public Health Sciences Division; Fred Hutchinson Cancer Research Center; Seattle Washington"}]}, {"given": "Cathryn", "family": "Rankin", "sequence": "additional", "affiliation": [{"name": "Southwest Oncology Group Statistical Center; Seattle Washington"}]}, {"given": "Adetunji T.", "family": "Toriola", "sequence": "additional", "affiliation": [{"name": "Department of Surgery, Division of Public Health Sciences and Siteman Cancer Center; Washington University School of Medicine; St. Louis Missouri"}]}, {"given": "Karen W.", "family": "Makar", "sequence": "additional", "affiliation": [{"name": "Public Health Sciences Division; Fred Hutchinson Cancer Research Center; Seattle Washington"}]}, {"given": "\u00d6zge", "family": "Altug-Teber", "sequence": "additional", "affiliation": [{"name": "Division of Preventive Oncology; National Center for Tumor Diseases; Heidelberg Germany"}, {"name": "German Cancer Research Center and German Consortium for Translational Cancer Research; Heidelberg Germany"}]}, {"given": "Jacqueline K.", "family": "Benedetti", "sequence": "additional", "affiliation": [{"name": "Southwest Oncology Group Statistical Center; Seattle Washington"}]}, {"given": "Rebecca S.", "family": "Holmes", "sequence": "additional", "affiliation": [{"name": "Knight Cancer Institute, Oregon Health and Science University; Portland Oregon"}]}, {"given": "Stephen R.", "family": "Smalley", "sequence": "additional", "affiliation": [{"name": "Radiation Oncology Center, Olathe Regional Oncology Center; Olathe Kansas"}]}, {"given": "Charles D.", "family": "Blanke", "sequence": "additional", "affiliation": [{"name": "Knight Cancer Institute, Oregon Health and Science University; Portland Oregon"}]}, {"given": "Heinz-Josef", "family": "Lenz", "sequence": "additional", "affiliation": [{"name": "Division of Medical Oncology, Keck School of Medicine, University of Southern California; Los Angeles California"}]}], "member": "311", "published-online": {"date-parts": [[2014, 7, 15]]}, "reference": [{"key": "10.1002/cncr.28830-BIB0001|cncr28830-cit-0001", "doi-asserted-by": "crossref", "first-page": "3542", "DOI": "10.1200/JCO.2005.04.9544", "article-title": "Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144", "volume": "24", "author": "Smalley", "year": "2006", "journal-title": "J Clin Oncol."}, {"key": "10.1002/cncr.28830-BIB0002|cncr28830-cit-0002", "doi-asserted-by": "crossref", "first-page": "1731", "DOI": "10.1056/NEJMoa040694", "article-title": "Preoperative versus postoperative chemoradiotherapy for rectal cancer", "volume": "351", "author": "Sauer", "year": "2004", "journal-title": "N Engl J Med."}, {"key": "10.1002/cncr.28830-BIB0003|cncr28830-cit-0003", "doi-asserted-by": "crossref", "first-page": "251", "DOI": "10.2217/pgs.10.167", "article-title": "5-fluorouracil pharmacogenomics: still rocking after all these years?", "volume": "12", "author": "Scartozzi", "year": "2011", "journal-title": "Pharmacogenomics."}, {"key": "10.1002/cncr.28830-BIB0004|cncr28830-cit-0004", "doi-asserted-by": "crossref", "first-page": "330", "DOI": "10.1038/nrc1074", "article-title": "5-fluorouracil: mechanisms of action and clinical strategies", "volume": "3", "author": "Longley", "year": "2003", "journal-title": "Nat Rev Cancer."}, {"key": "10.1002/cncr.28830-BIB0005|cncr28830-cit-0005", "doi-asserted-by": "crossref", "first-page": "856", "DOI": "10.1002/humu.20522", "article-title": "Large-scale population-based metabolic phenotyping of thirteen genetic polymorphisms related to one-carbon metabolism", "volume": "28", "author": "Fredriksen", "year": "2007", "journal-title": "Hum Mutat."}, {"key": "10.1002/cncr.28830-BIB0006|cncr28830-cit-0006", "doi-asserted-by": "crossref", "first-page": "164", "DOI": "10.1006/mgme.2001.3175", "article-title": "Is mutated serine hydroxymethyltransferase (SHMT) involved in the etiology of neural tube defects?", "volume": "73", "author": "Heil", "year": "2001", "journal-title": "Mol Genet Metab."}, {"key": "10.1002/cncr.28830-BIB0007|cncr28830-cit-0007", "doi-asserted-by": "crossref", "first-page": "617", "DOI": "10.1002/ijc.20148", "article-title": "Polymorphisms in the one-carbon metabolic pathway, plasma folate levels and colorectal cancer in a prospective study", "volume": "110", "author": "Chen", "year": "2004", "journal-title": "Int J Cancer."}, {"key": "10.1002/cncr.28830-BIB0008|cncr28830-cit-0008", "doi-asserted-by": "crossref", "first-page": "912", "DOI": "10.1038/nrc1233", "article-title": "Cancer pharmacogenetics: polymorphisms, pathways and beyond", "volume": "3", "author": "Ulrich", "year": "2003", "journal-title": "Nat Rev Cancer."}, {"key": "10.1002/cncr.28830-BIB0009|cncr28830-cit-0009", "doi-asserted-by": "crossref", "first-page": "673", "DOI": "10.2217/14622416.6.7.673", "article-title": "Pharmacogenetics of folate-related drug targets in cancer treatment", "volume": "6", "author": "Robien", "year": "2005", "journal-title": "Pharmacogenomics."}, {"key": "10.1002/cncr.28830-BIB0010|cncr28830-cit-0010", "doi-asserted-by": "crossref", "first-page": "111", "DOI": "10.1038/ng0595-111", "article-title": "A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase [letter]", "volume": "10", "author": "Frosst", "year": "1995", "journal-title": "Nat Genet."}, {"key": "10.1002/cncr.28830-BIB0011|cncr28830-cit-0011", "doi-asserted-by": "crossref", "first-page": "169", "DOI": "10.1006/mgme.1998.2714", "article-title": "A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity", "volume": "64", "author": "Weisberg", "year": "1998", "journal-title": "Mol Genet Metab."}, {"key": "10.1002/cncr.28830-BIB0012|cncr28830-cit-0012", "first-page": "5860", "article-title": "The folate pool in colorectal cancers is associated with DNA hypermethylation and with a polymorphism in methylenetetrahydrofolate reductase", "volume": "9", "author": "Kawakami", "year": "2003", "journal-title": "Clin Cancer Res."}, {"key": "10.1002/cncr.28830-BIB0013|cncr28830-cit-0013", "doi-asserted-by": "crossref", "first-page": "95", "DOI": "10.1016/S1084-8592(99)80034-4", "article-title": "MTHFR (C677T) polymorphisms and stage III colon cancer: response to therapy", "volume": "4", "author": "Wisotzkey", "year": "1999", "journal-title": "Mol Diagn."}, {"key": "10.1002/cncr.28830-BIB0014|cncr28830-cit-0014", "first-page": "1611", "article-title": "Methylenetetrahydrofolate reductase polymorphism in advanced colorectal cancer: a novel genomic predictor of clinical response to fluoropyrimidine-based chemotherapy", "volume": "9", "author": "Cohen", "year": "2003", "journal-title": "Clin Cancer Res."}, {"key": "10.1002/cncr.28830-BIB0015|cncr28830-cit-0015", "doi-asserted-by": "crossref", "first-page": "526", "DOI": "10.1038/sj.bjc.6601523", "article-title": "Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms: relationships with 5-fluorouracil sensitivity", "volume": "90", "author": "Etienne", "year": "2004", "journal-title": "Br J Cancer."}, {"key": "10.1002/cncr.28830-BIB0016|cncr28830-cit-0016", "doi-asserted-by": "crossref", "first-page": "1365", "DOI": "10.1200/JCO.2005.06.219", "article-title": "Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphism in normal tissue as predictors of fluorouracil sensitivity", "volume": "23", "author": "Jakobsen", "year": "2005", "journal-title": "J Clin Oncol."}, {"key": "10.1002/cncr.28830-BIB0017|cncr28830-cit-0017", "doi-asserted-by": "crossref", "first-page": "256", "DOI": "10.1038/sj.tpj.6500476", "article-title": "The influence of fluorouracil outcome parameters on tolerance and efficacy in patients with advanced colorectal cancer", "volume": "8", "author": "Capitain", "year": "2008", "journal-title": "Pharmacogenomics J."}, {"key": "10.1002/cncr.28830-BIB0018|cncr28830-cit-0018", "doi-asserted-by": "crossref", "first-page": "1549", "DOI": "10.1038/sj.bjc.6605052", "article-title": "Predictors of survival and toxicity in patients on adjuvant therapy with 5-fluorouracil for colorectal cancer", "volume": "100", "author": "Gusella", "year": "2009", "journal-title": "Br J Cancer."}, {"key": "10.1002/cncr.28830-BIB0019|cncr28830-cit-0019", "doi-asserted-by": "crossref", "first-page": "998", "DOI": "10.1038/sj.bjc.6605239", "article-title": "Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer", "volume": "101", "author": "Chua", "year": "2009", "journal-title": "Br J Cancer."}, {"key": "10.1002/cncr.28830-BIB0020|cncr28830-cit-0020", "doi-asserted-by": "crossref", "first-page": "835", "DOI": "10.1007/s00280-005-0089-1", "article-title": "Methylenetetrahydrofolate reductase gene polymorphisms: genomic predictors of clinical response to fluoropyrimidine-based chemotherapy?", "volume": "57", "author": "Marcuello", "year": "2006", "journal-title": "Cancer Chemother Pharmacol."}, {"key": "10.1002/cncr.28830-BIB0021|cncr28830-cit-0021", "doi-asserted-by": "crossref", "first-page": "1379", "DOI": "10.1245/s10434-006-9112-y", "article-title": "Which gene is a dominant predictor of response during FOLFOX chemotherapy for the treatment of metastatic colorectal cancer, the MTHFR or XRCC1 gene?", "volume": "13", "author": "Suh", "year": "2006", "journal-title": "Ann Surg Oncol."}, {"key": "10.1002/cncr.28830-BIB0022|cncr28830-cit-0022", "doi-asserted-by": "crossref", "first-page": "1247", "DOI": "10.1200/JCO.2006.08.1844", "article-title": "Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFOX-4 chemotherapy", "volume": "25", "author": "Ruzzo", "year": "2007", "journal-title": "J Clin Oncol."}, {"key": "10.1002/cncr.28830-BIB0023|cncr28830-cit-0023", "doi-asserted-by": "crossref", "first-page": "161", "DOI": "10.1097/FPC.0b013e3282f4aea6", "article-title": "Thymidylate synthase haplotype is associated with tumor recurrence in stage II and stage III colon cancer", "volume": "18", "author": "Lurje", "year": "2008", "journal-title": "Pharmacogenet Genomics."}, {"key": "10.1002/cncr.28830-BIB0024|cncr28830-cit-0024", "doi-asserted-by": "crossref", "first-page": "5519", "DOI": "10.1200/JCO.2008.21.6283", "article-title": "Association of molecular markers with toxicity outcomes in a randomized trial of chemotherapy for advanced colorectal cancer: the FOCUS trial", "volume": "27", "author": "Braun", "year": "2009", "journal-title": "J Clin Oncol."}, {"key": "10.1002/cncr.28830-BIB0025|cncr28830-cit-0025", "doi-asserted-by": "crossref", "first-page": "1660", "DOI": "10.1093/annonc/mdp046", "article-title": "MTHFR polymorphisms and 5-FU-based adjuvant chemotherapy in colorectal cancer", "volume": "20", "author": "Afzal", "year": "2009", "journal-title": "Ann Oncol."}, {"key": "10.1002/cncr.28830-BIB0026|cncr28830-cit-0026", "doi-asserted-by": "crossref", "first-page": "58", "DOI": "10.1111/j.1365-2125.2009.03556.x", "article-title": "Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and FOLFOX response in colorectal cancer patients", "volume": "69", "author": "Etienne-Grimaldi", "year": "2010", "journal-title": "Br J Clin Pharmacol."}, {"key": "10.1002/cncr.28830-BIB0027|cncr28830-cit-0027", "doi-asserted-by": "crossref", "first-page": "61", "DOI": "10.1038/tpj.2010.10", "article-title": "Prediction of irinotecan and 5-fluorouracil toxicity and response in patients with advanced colorectal cancer", "volume": "11", "author": "Glimelius", "year": "2011", "journal-title": "Pharmacogenomics J."}, {"key": "10.1002/cncr.28830-BIB0028|cncr28830-cit-0028", "doi-asserted-by": "crossref", "first-page": "7", "DOI": "10.1161/01.CIR.93.1.7", "article-title": "Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations [see comments]", "volume": "93", "author": "Jacques", "year": "1996", "journal-title": "Circulation."}, {"key": "10.1002/cncr.28830-BIB0029|cncr28830-cit-0029", "doi-asserted-by": "crossref", "first-page": "134", "DOI": "10.1093/jnci/djh015", "article-title": "Effect of the methylenetetrahydrofolate reductase C677T polymorphism on chemosensitivity of colon and breast cancer cells to 5-fluorouracil and methotrexate", "volume": "96", "author": "Sohn", "year": "2004", "journal-title": "J Natl Cancer Inst."}, {"key": "10.1002/cncr.28830-BIB0030|cncr28830-cit-0030", "doi-asserted-by": "crossref", "first-page": "13217", "DOI": "10.1073/pnas.95.22.13217", "article-title": "A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells", "volume": "95", "author": "Bagley", "year": "1998", "journal-title": "Proc Natl Acad Sci U S A."}, {"key": "10.1002/cncr.28830-BIB0031|cncr28830-cit-0031", "doi-asserted-by": "crossref", "first-page": "817", "DOI": "10.1097/01.fpc.0000230412.89973.c0", "article-title": "A haplotype of the methylenetetrahydrofolate reductase gene predicts poor tumor response in rectal cancer patients receiving preoperative chemoradiation", "volume": "16", "author": "Terrazzino", "year": "2006", "journal-title": "Pharmacogenet Genomics."}, {"key": "10.1002/cncr.28830-BIB0032|cncr28830-cit-0032", "doi-asserted-by": "crossref", "first-page": "1654", "DOI": "10.1038/bjc.2011.442", "article-title": "Methylenetetrahydrofolate reductase genetic polymorphisms and toxicity to 5-FU-based chemoradiation in rectal cancer", "volume": "105", "author": "Thomas", "year": "2011", "journal-title": "Br J Cancer."}, {"key": "10.1002/cncr.28830-BIB0033|cncr28830-cit-0033", "doi-asserted-by": "crossref", "first-page": "214", "DOI": "10.1038/tpj.2010.25", "article-title": "Tumor response is predicted by patient genetic profile in rectal cancer patients treated with neo-adjuvant chemo-radiotherapy", "volume": "11", "author": "Cecchin", "year": "2011", "journal-title": "Pharmacogenomics J."}, {"key": "10.1002/cncr.28830-BIB0034|cncr28830-cit-0034", "doi-asserted-by": "crossref", "first-page": "2410", "DOI": "10.1161/01.CIR.94.10.2410", "article-title": "Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians [see comments]", "volume": "94", "author": "Ma", "year": "1996", "journal-title": "Circulation."}, {"key": "10.1002/cncr.28830-BIB0035|cncr28830-cit-0035", "first-page": "1381", "article-title": "Searching expressed sequence tag databases: discovery and confirmation of a common polymorphism in the thymidylate synthase gene", "volume": "9", "author": "Ulrich", "year": "2000", "journal-title": "Cancer Epidemiol Biomarkers Prev."}, {"key": "10.1002/cncr.28830-BIB0036|cncr28830-cit-0036", "doi-asserted-by": "crossref", "first-page": "1779", "DOI": "10.1200/JCO.2001.19.6.1779", "article-title": "Polymorphisms of the repeated sequences in the enhancer region of the thymidylate synthase gene promoter may predict downstaging after preoperative chemoradiation in rectal cancer", "volume": "19", "author": "Villafranca", "year": "2001", "journal-title": "J Clin Oncol."}, {"key": "10.1002/cncr.28830-BIB0037|cncr28830-cit-0037", "doi-asserted-by": "crossref", "first-page": "669", "DOI": "10.1016/j.ijrobp.2010.06.049", "article-title": "Thymidylate synthase gene polymorphism affects the response to preoperative 5-fluorouracil chemoradiation therapy in patients with rectal cancer", "volume": "81", "author": "Hur", "year": "2011", "journal-title": "Int J Radiat Oncol Biol Phys."}, {"key": "10.1002/cncr.28830-BIB0038|cncr28830-cit-0038", "doi-asserted-by": "crossref", "first-page": "428", "DOI": "10.1111/codi.12009", "article-title": "Prognostic significance of thymidylate synthase polymorphisms in rectal cancer patients treated with neoadjuvant chemoradiotherapy", "volume": "15", "author": "Arrazubi", "year": "2013", "journal-title": "Colorectal Dis."}, {"key": "10.1002/cncr.28830-BIB0039|cncr28830-cit-0039", "doi-asserted-by": "crossref", "first-page": "1681", "DOI": "10.1007/s00432-010-0826-7", "article-title": "Thymidylate synthase germline polymorphisms in rectal cancer patients treated with neoadjuvant chemoradiotherapy based on 5-fluorouracil", "volume": "136", "author": "Paez", "year": "2010", "journal-title": "J Cancer Res Clin Oncol."}, {"key": "10.1002/cncr.28830-BIB0040|cncr28830-cit-0040", "doi-asserted-by": "crossref", "first-page": "2323", "DOI": "10.3945/jn.108.096404", "article-title": "A 19-base pair deletion polymorphism in dihydrofolate reductase is associated with increased unmetabolized folic acid in plasma and decreased red blood cell folate", "volume": "138", "author": "Kalmbach", "year": "2008", "journal-title": "J Nutr."}, {"key": "10.1002/cncr.28830-BIB0041|cncr28830-cit-0041", "doi-asserted-by": "crossref", "first-page": "103", "DOI": "10.1038/sj.ejhg.5201713", "article-title": "Molecular genetic analysis of the human dihydrofolate reductase gene: relation with plasma total homocysteine, serum and red blood cell folate levels", "volume": "15", "author": "Gellekink", "year": "2006", "journal-title": "Eur J Hum Genet."}, {"key": "10.1002/cncr.28830-BIB0042|cncr28830-cit-0042", "doi-asserted-by": "crossref", "first-page": "289", "DOI": "10.1007/s00439-008-0475-y", "article-title": "An insertion/deletion polymorphism of the dihydrofolate reductase (DHFR) gene is associated with serum and red blood cell folate concentrations in women", "volume": "123", "author": "Stanislawska-Sachadyn", "year": "2008", "journal-title": "Hum Genet."}, {"key": "10.1002/cncr.28830-BIB0043|cncr28830-cit-0043", "doi-asserted-by": "crossref", "first-page": "1098", "DOI": "10.1093/ajcn/85.4.1098", "article-title": "A functional 19-base pair deletion polymorphism of dihydrofolate reductase (DHFR) and risk of breast cancer in multivitamin users", "volume": "85", "author": "Xu", "year": "2007", "journal-title": "Am J Clin Nutr."}, {"key": "10.1002/cncr.28830-BIB0044|cncr28830-cit-0044", "doi-asserted-by": "crossref", "first-page": "799", "DOI": "10.1038/sj.bmt.1705330", "article-title": "Methylenetetrahydrofolate reductase and thymidylate synthase genotypes modify oral mucositis severity following hematopoietic stem cell transplantation", "volume": "37", "author": "Robien", "year": "2006", "journal-title": "Bone Marrow Transplant."}], "container-title": ["Cancer"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcncr.28830", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 8, 12]], "date-time": "2019-08-12T21:17:43Z", "timestamp": 1565644663000}, "score": 31.945536, "subtitle": ["Folate Polymorphisms and Response to 5-FU"], "issued": {"date-parts": [[2014, 7, 15]]}, "references-count": 44, "journal-issue": {"published-print": {"date-parts": [[2014, 11, 1]]}, "issue": "21"}, "URL": "http://dx.doi.org/10.1002/cncr.28830", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["0008-543X"], "issn-type": [{"value": "0008-543X", "type": "print"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T01:27:37Z", "timestamp": 1574818057169}, "reference-count": 42, "publisher": "Springer Science and Business Media LLC", "issue": "1", "license": [{"URL": "https://creativecommons.org/licenses/by/4.0", "start": {"date-parts": [[2016, 7, 1]], "date-time": "2016-07-01T00:00:00Z", "timestamp": 1467331200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Sci Rep"], "published-print": {"date-parts": [[2016, 7]]}, "DOI": "10.1038/srep29555", "type": "journal-article", "created": {"date-parts": [[2016, 7, 12]], "date-time": "2016-07-12T14:31:36Z", "timestamp": 1468333896000}, "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 3, "title": ["Joint effects of folate intake and one-carbon-metabolizing genetic polymorphisms on breast cancer risk: a case-control study in China"], "prefix": "10.1038", "volume": "6", "author": [{"given": "Wei-Ping", "family": "Luo", "sequence": "first", "affiliation": []}, {"given": "Bin", "family": "Li", "sequence": "additional", "affiliation": []}, {"given": "Fang-Yu", "family": "Lin", "sequence": "additional", "affiliation": []}, {"given": "Bo", "family": "Yan", "sequence": "additional", "affiliation": []}, {"given": "Yu-Feng", "family": "Du", "sequence": "additional", "affiliation": []}, {"given": "Xiong-Fei", "family": "Mo", "sequence": "additional", "affiliation": []}, {"given": "Lian", "family": "Wang", "sequence": "additional", "affiliation": []}, {"given": "Cai-Xia", "family": "Zhang", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2016, 7, 12]]}, "reference": [{"key": "BFsrep29555_CR1", "doi-asserted-by": "publisher", "first-page": "1140", "DOI": "10.1158/1055-9965.epi-06-1037", "volume": "16", "author": "VL Stevens", "year": "2007", "unstructured": "Stevens, V. L. et al. Association of polymorphisms in one-carbon metabolism genes and postmenopausal breast cancer incidence. Cancer Epidemiol Biomarkers Prev 16, 1140\u20131147, doi: 10.1158/1055-9965.epi-06-1037 (2007).", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"key": "BFsrep29555_CR2", "doi-asserted-by": "publisher", "first-page": "2696", "DOI": "10.1002/ijc.22604", "volume": "120", "author": "J Lissowska", "year": "2007", "unstructured": "Lissowska, J. et al. Genetic polymorphisms in the one-carbon metabolism pathway and breast cancer risk: a population-based case-control study and meta-analyses. Int J Cancer 120, 2696\u20132703, doi: 10.1002/ijc.22604 (2007).", "journal-title": "Int J Cancer"}, {"key": "BFsrep29555_CR3", "doi-asserted-by": "publisher", "first-page": "3290", "DOI": "10.1073/pnas.94.7.3290", "volume": "94", "author": "BC Blount", "year": "1997", "unstructured": "Blount, B. C. et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA 94, 3290\u20133295 (1997).", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFsrep29555_CR4", "doi-asserted-by": "publisher", "first-page": "386", "DOI": "10.1093/ajcn/54.2.386", "volume": "54", "author": "KJ Storch", "year": "1991", "unstructured": "Storch, K. J., Wagner, D. A. & Young, V. R. Methionine kinetics in adult men: effects of dietary betaine on L-[2H3-methyl-1-13C] methionine. The American journal of clinical nutrition 54, 386\u2013394 (1991).", "journal-title": "The American journal of clinical nutrition"}, {"key": "BFsrep29555_CR5", "doi-asserted-by": "publisher", "first-page": "1607", "DOI": "10.1093/jnci/djj440", "volume": "98", "author": "SJ Lewis", "year": "2006", "unstructured": "Lewis, S. J., Harbord, R. M., Harris, R. & Smith, G. D. Meta-analyses of observational and genetic association studies of folate intakes or levels and breast cancer risk. Journal of the National Cancer Institute 98, 1607\u20131622 (2006).", "journal-title": "Journal of the National Cancer Institute"}, {"key": "BFsrep29555_CR6", "doi-asserted-by": "publisher", "first-page": "1270", "DOI": "10.1093/jnci/92.15.1270-a", "volume": "92", "author": "E Negri", "year": "2000", "unstructured": "Negri, E., La Vecchia, C. & Franceschi, S. Re: Dietary folate consumption and breast cancer risk. Journal of the National Cancer Institute 92, 1270\u20131271 (2000).", "journal-title": "Journal of the National Cancer Institute"}, {"key": "BFsrep29555_CR7", "doi-asserted-by": "publisher", "first-page": "111", "DOI": "10.1207/s15327914nc352_3", "volume": "35", "author": "A Ronco", "year": "1999", "unstructured": "Ronco, A. et al. Vegetables, fruits, and related nutrients and risk of breast cancer: a case-control study in Uruguay. Nutr Cancer 35, 111\u2013119, doi: 10.1207/s15327914nc352_3 (1999).", "journal-title": "Nutr Cancer"}, {"key": "BFsrep29555_CR8", "doi-asserted-by": "publisher", "first-page": "190", "DOI": "10.1158/1055-9965.EPI-03-0273", "volume": "13", "author": "MJ Shrubsole", "year": "2004", "unstructured": "Shrubsole, M. J. et al. MTHFR polymorphisms, dietary folate intake, and breast cancer risk: Results from the Shanghai breast cancer study. Cancer Epidemiology Biomarkers & Prevention 13, 190\u2013196 (2004).", "journal-title": "Cancer Epidemiology Biomarkers & Prevention"}, {"key": "BFsrep29555_CR9", "doi-asserted-by": "publisher", "first-page": "64", "DOI": "10.1093/jnci/djk006", "volume": "99", "author": "SC Larsson", "year": "2007", "unstructured": "Larsson, S. C., Giovannucci, E. & Wolk, A. Folate and risk of breast cancer: A meta-analysis. Journal of the National Cancer Institute 99, 64\u201376 (2007).", "journal-title": "Journal of the National Cancer Institute"}, {"key": "BFsrep29555_CR10", "doi-asserted-by": "publisher", "first-page": "2295", "DOI": "10.1093/carcin/bgl108", "volume": "27", "author": "YC Chou", "year": "2006", "unstructured": "Chou, Y. C. et al. Genetic polymorphisms of the methylenetetrahydrofolate reductase gene, plasma folate levels and breast cancer susceptibility: a case-control study in Taiwan. Carcinogenesis 27, 2295\u20132300, doi: 10.1093/carcin/bgl108 (2006).", "journal-title": "Carcinogenesis"}, {"key": "BFsrep29555_CR11", "doi-asserted-by": "publisher", "first-page": "1606", "DOI": "10.1158/0008-5472.CAN-04-2630", "volume": "65", "author": "J Chen", "year": "2005", "unstructured": "Chen, J. et al. One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer. Cancer Research 65, 1606\u20131614 (2005).", "journal-title": "Cancer Research"}, {"key": "BFsrep29555_CR12", "doi-asserted-by": "publisher", "first-page": "936", "DOI": "10.1017/S0007114511001140", "volume": "106", "author": "CX Zhang", "year": "2011", "unstructured": "Zhang, C. X. et al. Dietary folate, vitamin B6, vitamin B12 and methionine intake and the risk of breast cancer by oestrogen and progesterone receptor status. British Journal of Nutrition 106, 936 (2011).", "journal-title": "British Journal of Nutrition"}, {"key": "BFsrep29555_CR13", "doi-asserted-by": "publisher", "first-page": "122", "DOI": "10.1186/1471-2407-9-122", "volume": "9", "author": "E Ma", "year": "2009", "unstructured": "Ma, E. et al. Dietary intake of folate, vitamin B6, and vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: a case-control study in Brazilian women. BMC cancer 9, 122 (2009).", "journal-title": "BMC cancer"}, {"key": "BFsrep29555_CR14", "doi-asserted-by": "publisher", "first-page": "885", "DOI": "10.1007/s10549-010-0804-4", "volume": "123", "author": "S Sangrajrang", "year": "2010", "unstructured": "Sangrajrang, S. et al. Genetic polymorphisms in folate and alcohol metabolism and breast cancer risk: a case-control study in Thai women. Breast Cancer Res Treat 123, 885\u2013893, doi: 10.1007/s10549-010-0804-4 (2010).", "journal-title": "Breast Cancer Res Treat"}, {"key": "BFsrep29555_CR15", "doi-asserted-by": "publisher", "first-page": "998", "DOI": "10.1158/1055-9965.EPI-08-0916", "volume": "18", "author": "MH Tao", "year": "2009", "unstructured": "Tao, M. H. et al. DNA Promoter Methylation in Breast Tumors: No Association with Genetic Polymorphisms in MTHFR and MTR. Cancer Epidemiology Biomarkers & Prevention 18, 998\u20131002 (2009).", "journal-title": "Cancer Epidemiology Biomarkers & Prevention"}, {"key": "BFsrep29555_CR16", "doi-asserted-by": "publisher", "first-page": "1133", "DOI": "10.1007/s13277-012-0354-y", "volume": "33", "author": "B Lajin", "year": "2012", "unstructured": "Lajin, B., Alhaj Sakur, A., Ghabreau, L. & Alachkar, A. Association of polymorphisms in one-carbon metabolizing genes with breast cancer risk in Syrian women. Tumour Biol 33, 1133\u20131139, doi: 10.1007/s13277-012-0354-y (2012).", "journal-title": "Tumour Biol"}, {"key": "BFsrep29555_CR17", "doi-asserted-by": "publisher", "first-page": "74", "DOI": "10.1016/j.mrgentox.2010.12.008", "volume": "721", "author": "B Pardini", "year": "2011", "unstructured": "Pardini, B. et al. MTHFR and MTRR genotype and haplotype analysis and colorectal cancer susceptibility in a case\u2013control study from the Czech Republic. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 721, 74\u201380 (2011).", "journal-title": "Mutation Research/Genetic Toxicology and Environmental Mutagenesis"}, {"key": "BFsrep29555_CR18", "doi-asserted-by": "publisher", "first-page": "23", "DOI": "10.1007/s10552-009-9430-z", "volume": "21", "author": "SY Tong", "year": "2010", "unstructured": "Tong, S. Y. et al. The effects of polymorphisms in methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTR), and methionine synthase reductase (MTRR) on the risk of cervical intraepithelial neoplasia and cervical cancer in Korean women. Cancer Causes & Control, 21, 23\u201330 (2010).", "journal-title": "Cancer Causes & Control"}, {"key": "BFsrep29555_CR19", "doi-asserted-by": "publisher", "first-page": "184", "DOI": "10.5808/GI.2012.10.3.184", "volume": "10", "author": "JY Yoo", "year": "2012", "unstructured": "Yoo, J. Y. et al. Association study between folate pathway gene single nucleotide polymorphisms and gastric cancer in Koreans. Genomics & informatics 10, 184\u2013193 (2012).", "journal-title": "Genomics & informatics"}, {"key": "BFsrep29555_CR20", "doi-asserted-by": "publisher", "first-page": "37", "DOI": "10.2174/1389200052997339", "volume": "6", "author": "S Friso", "year": "2005", "unstructured": "Friso, S. & Choi, S. W. Gene-nutrient interactions in one-carbon metabolism. Current drug metabolism 6, 37\u201346 (2005).", "journal-title": "Current drug metabolism"}, {"key": "BFsrep29555_CR21", "doi-asserted-by": "publisher", "first-page": "88", "DOI": "10.1080/07853890252953473", "volume": "34", "author": "JH Moore", "year": "2002", "unstructured": "Moore, J. H. & Williams, S. M. New strategies for identifying gene-gene interactions in hypertension. Annals of medicine 34, 88\u201395 (2002).", "journal-title": "Annals of medicine"}, {"key": "BFsrep29555_CR22", "doi-asserted-by": "publisher", "first-page": "2160", "DOI": "10.1093/carcin/bgm167", "volume": "28", "author": "M Chen", "year": "2007", "unstructured": "Chen, M. et al. High-order interactions among genetic polymorphisms in nucleotide excision repair pathway genes and smoking in modulating bladder cancer risk. Carcinogenesis 28, 2160\u20132165 (2007).", "journal-title": "Carcinogenesis"}, {"key": "BFsrep29555_CR23", "first-page": "917", "volume": "11", "author": "A F\u00f6rsti", "year": "2004", "unstructured": "F\u00f6rsti, A. et al. Single nucleotide polymorphisms in breast cancer. Oncology reports 11, 917\u2013922 (2004).", "journal-title": "Oncology reports"}, {"key": "BFsrep29555_CR24", "doi-asserted-by": "publisher", "first-page": "720", "DOI": "10.1134/S0026893310050067", "volume": "44", "author": "A Weiner", "year": "2010", "unstructured": "Weiner, A. et al. Polymorphic variants of folate metabolizing genes (C677T and A1298C MTHFR and C1420T SHMT1 and G1958A MTHFD) are not associated with the risk of breast cancer in the West Siberian Region of Russia. Molecular biology 44, 720\u2013727 (2010).", "journal-title": "Molecular biology"}, {"key": "BFsrep29555_CR25", "first-page": "175", "volume": "4", "author": "J Ziva Cerne", "year": "2011", "unstructured": "Ziva Cerne, J., Stegel, V., Gersak, K. & Novakovic, S. Lack of association between methylenetetrahydrofolate reductase genetic polymorphisms and postmenopausal breast cancer risk. Molecular medicine reports 4, 175\u2013179 (2011).", "journal-title": "Molecular medicine reports"}, {"key": "BFsrep29555_CR26", "doi-asserted-by": "publisher", "first-page": "65", "DOI": "10.1016/S0304-3835(02)00030-7", "volume": "181", "author": "L Sharp", "year": "2002", "unstructured": "Sharp, L. et al. Folate and breast cancer: the role of polymorphisms in methylenetetrahydrofolate reductase (MTHFR). Cancer letters 181, 65\u201371 (2002).", "journal-title": "Cancer letters"}, {"key": "BFsrep29555_CR27", "doi-asserted-by": "publisher", "first-page": "286", "DOI": "10.1159/000076460", "volume": "24", "author": "EEASZ Utkanb", "year": "2003", "unstructured": "Utkanb, E. E. A. S. Z. & Canturkb, N. Z. Polymorphisms in the MTHFR gene are associated with breast cancer. Tumor Biol 24, 286\u2013290 (2003).", "journal-title": "Tumor Biol"}, {"key": "BFsrep29555_CR28", "first-page": "576", "volume": "43", "author": "C Gao", "year": "2009", "unstructured": "Gao, C. et al. MTHFR polymorphisms, dietary folate intake and risks to breast cancer. Chinese journal of preventive medicine 43, 576\u2013580 (2009).", "journal-title": "Chinese journal of preventive medicine"}, {"key": "BFsrep29555_CR29", "doi-asserted-by": "publisher", "first-page": "1044", "DOI": "10.1086/301825", "volume": "62", "author": "NM van der Put", "year": "1998", "unstructured": "van der Put, N. M. et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? The American Journal of Human Genetics 62, 1044\u20131051 (1998).", "journal-title": "The American Journal of Human Genetics"}, {"key": "BFsrep29555_CR30", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1186/1471-2288-2-8", "volume": "2", "author": "RJ Feise", "year": "2002", "unstructured": "Feise, R. J. Do multiple outcome measures require p-value adjustment? BMC Medical Research Methodology 2, 1 (2002).", "journal-title": "BMC Medical Research Methodology"}, {"key": "BFsrep29555_CR31", "doi-asserted-by": "publisher", "first-page": "512", "DOI": "10.1111/j.1399-0004.2006.00618.x", "volume": "69", "author": "A Mostowska", "year": "2006", "unstructured": "Mostowska, A., Hozyasz, K. & Jagodzinski, P. Maternal MTR genotype contributes to the risk of non\u2010syndromic cleft lip and palate in the Polish population. Clinical genetics 69, 512\u2013517 (2006).", "journal-title": "Clinical genetics"}, {"key": "BFsrep29555_CR32", "doi-asserted-by": "publisher", "first-page": "5571", "DOI": "10.1007/s11033-014-3462-5", "volume": "41", "author": "F Copped\u00e8", "year": "2014", "unstructured": "Copped\u00e8, F. et al. The MTRR 66A&gt; G polymorphism and maternal risk of birth of a child with Down syndrome in Caucasian women: a case\u2013control study and a meta-analysis. Molecular biology reports 41, 5571\u20135583 (2014).", "journal-title": "Molecular biology reports"}, {"key": "BFsrep29555_CR33", "doi-asserted-by": "publisher", "first-page": "R91", "DOI": "10.1186/bcr2462", "volume": "11", "author": "SS Maruti", "year": "2009", "unstructured": "Maruti, S. S., Ulrich, C. M., Jupe, E. R. & White, E. MTHFR C677T and postmenopausal breast cancer risk by intakes of one-carbon metabolism nutrients: a nested case-control study. Breast Cancer Research 11, R91, doi: 10.1186/bcr2462 (2009).", "journal-title": "Breast Cancer Research"}, {"key": "BFsrep29555_CR34", "doi-asserted-by": "publisher", "first-page": "111", "DOI": "10.1038/ng0595-111", "volume": "10", "author": "P Frosst", "year": "1995", "unstructured": "Frosst, P. et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10, 111\u2013113, doi: 10.1038/ng0595-111 (1995).", "journal-title": "Nat Genet"}, {"key": "BFsrep29555_CR35", "doi-asserted-by": "publisher", "first-page": "578", "DOI": "10.1258/0007142991902646", "volume": "55", "author": "SJ Duthie", "year": "1999", "unstructured": "Duthie, S. J. Folic acid deficiency and cancer: mechanisms of DNA instability. British medical bulletin 55, 578\u2013592 (1999).", "journal-title": "British medical bulletin"}, {"key": "BFsrep29555_CR36", "doi-asserted-by": "publisher", "first-page": "138", "DOI": "10.1086/321276", "volume": "69", "author": "MD Ritchie", "year": "2001", "unstructured": "Ritchie, M. D. et al. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. The American Journal of Human Genetics 69, 138\u2013147 (2001).", "journal-title": "The American Journal of Human Genetics"}, {"key": "BFsrep29555_CR37", "unstructured": "Kuppuswamy, B. Manual of socioeconomic status scale (urban). Delhi: Manasayan (1981)."}, {"key": "BFsrep29555_CR38", "unstructured": "Yang, Y. X., Wang, G. Y. & Pan, X. C. China food composition. Peking University Medical Press, Beijing 329 (2002)."}, {"key": "BFsrep29555_CR39", "doi-asserted-by": "publisher", "first-page": "1508", "DOI": "10.1111/j.1538-7836.2012.04815.x", "volume": "10", "author": "X Chen", "year": "2012", "unstructured": "Chen, X. et al. Genome-wide association study validation identifies novel loci for atherosclerotic cardiovascular disease. Journal of Thrombosis and Haemostasis 10, 1508\u20131514 (2012).", "journal-title": "Journal of Thrombosis and Haemostasis"}, {"key": "BFsrep29555_CR40", "doi-asserted-by": "publisher", "first-page": "1220S", "DOI": "10.1093/ajcn/65.4.1220S", "volume": "65", "author": "WC Willett", "year": "1997", "unstructured": "Willett, W. C., Howe, G. R. & Kushi, L. H. Adjustment for total energy intake in epidemiologic studies. The American journal of clinical nutrition 65, 1220S\u20131228S (1997).", "journal-title": "The American journal of clinical nutrition"}, {"key": "BFsrep29555_CR41", "doi-asserted-by": "publisher", "first-page": "621", "DOI": "10.7314/APJCP.2012.13.2.621", "volume": "13", "author": "N Song", "year": "2012", "unstructured": "Song, N. et al. Genetic variants in interleukin-2 and risk of lymphoma among children in Korea. Asian Pacific Journal of Cancer Prevention 13, 621\u2013623 (2012).", "journal-title": "Asian Pacific Journal of Cancer Prevention"}, {"key": "BFsrep29555_CR42", "doi-asserted-by": "publisher", "first-page": "106", "DOI": "10.1086/381000", "volume": "74", "author": "CS Carlson", "year": "2004", "unstructured": "Carlson, C. S. et al. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. The American Journal of Human Genetics 74, 106\u2013120 (2004).", "journal-title": "The American Journal of Human Genetics"}], "container-title": ["Scientific Reports"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/srep29555.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/srep29555", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/srep29555.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 16]], "date-time": "2019-05-16T15:12:10Z", "timestamp": 1558019530000}, "score": 31.507778, "issued": {"date-parts": [[2016, 7]]}, "references-count": 42, "journal-issue": {"published-print": {"date-parts": [[2016, 7]]}, "issue": "1"}, "alternative-id": ["BFsrep29555"], "URL": "http://dx.doi.org/10.1038/srep29555", "relation": {"cites": []}, "ISSN": ["2045-2322"], "issn-type": [{"value": "2045-2322", "type": "electronic"}], "assertion": [{"value": "14 March 2016", "order": 1, "name": "received", "label": "Received", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "20 June 2016", "order": 2, "name": "accepted", "label": "Accepted", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "12 July 2016", "order": 3, "name": "first_online", "label": "First Online", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "The authors declare no competing financial interests.", "order": 1, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Competing interests"}}], "article-number": "29555"}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T19:20:19Z", "timestamp": 1575141619643}, "reference-count": 46, "publisher": "Oxford University Press (OUP)", "issue": "8", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2005, 8, 1]]}, "DOI": "10.1093/carcin/bgi090", "type": "journal-article", "created": {"date-parts": [[2005, 4, 8]], "date-time": "2005-04-08T00:23:57Z", "timestamp": 1112919837000}, "page": "1430-1435", "source": "Crossref", "is-referenced-by-count": 26, "title": ["Significant increase in risk of gastroesophageal cancer is associated with interaction between promoter polymorphisms in thymidylate synthase and serum folate status"], "prefix": "10.1093", "volume": "26", "author": [{"given": "Wen", "family": "Tan", "sequence": "first", "affiliation": []}, {"given": "Xiaoping", "family": "Miao", "sequence": "additional", "affiliation": []}, {"given": "Li", "family": "Wang", "sequence": "additional", "affiliation": []}, {"given": "Chunyuan", "family": "Yu", "sequence": "additional", "affiliation": []}, {"given": "Ping", "family": "Xiong", "sequence": "additional", "affiliation": []}, {"given": "Gang", "family": "Liang", "sequence": "additional", "affiliation": []}, {"given": "Tong", "family": "Sun", "sequence": "additional", "affiliation": []}, {"given": "Yifeng", "family": "Zhou", "sequence": "additional", "affiliation": []}, {"given": "Xuemei", "family": "Zhang", "sequence": "additional", "affiliation": []}, {"given": "Hui", "family": "Li", "sequence": "additional", "affiliation": []}, {"given": "Dongxin", "family": "Lin", "sequence": "additional", "affiliation": []}], "member": "286", "published-online": {"date-parts": [[2005, 4, 7]]}, "reference": [{"key": "key\n\t\t\t\t20171011205412_B1", "unstructured": "Kamb,A., Finer-Moore,J., Calvert,A.H. and Stroud,R.M. ( 1992 ) Structural basis for recognition of polyglutamyl folates by thymidylate synthase. Biochemistry , 31 , 9883 \u20139890.", "DOI": "10.1021/bi00156a005", "doi-asserted-by": "crossref"}, {"key": "key\n\t\t\t\t20171011205412_B2", "unstructured": "Zhang,Z.F., Kurtz,R.C., Yu,G.P., Sun,M., Gargon,N., Karpeh,M.J., Fein,J.S. and Harlap,S. ( 1977 ) Adenocarcinomas of the esophagus and gastric cardia: the role of diet. Nutr. Cancer , 27 , 298 \u2013309.", "DOI": "10.1080/01635589709514541", "doi-asserted-by": "crossref"}, {"key": "key\n\t\t\t\t20171011205412_B3", "unstructured": "Mayne,S.T., Risch,H.A., Dubrow,R. et al . ( 2001 ) Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol. Biomarkers Prev. , 10 , 1055 \u20131062."}, {"key": "key\n\t\t\t\t20171011205412_B4", "unstructured": "Hu,J., Nyren,O., Wolk,A. et al . ( 1994 ) Risk factors for esophageal cancer in northeast China. Int. J. Cancer , 57 , 38 \u201346.", "DOI": "10.1002/ijc.2910570108", "doi-asserted-by": "crossref"}, {"key": "key\n\t\t\t\t20171011205412_B5", "unstructured": "Engel,L.S., Chow,W.H., Vaughan,T.L. et al . ( 2003 ) Population attributable risks of esophageal and gastric cancers. J. Natl. Cancer Inst. , 95 , 1404 \u20131413.", "DOI": "10.1093/jnci/djg047", "doi-asserted-by": "crossref"}, {"key": "key\n\t\t\t\t20171011205412_B6", "unstructured": "James,S.J., Miller,B.J., Basnakian,A.G., Pogribny,I.P., Pogribna,M. and Muskhelishvili,L. ( 1997 ) Apoptosis and proliferation under conditions of deoxynucleotide pool imbalance in liver of folate/methyl deficient rats. Carcinogenesis , 18 , 287 \u2013293.", "DOI": "10.1093/carcin/18.2.287", "doi-asserted-by": "crossref"}, {"key": "key\n\t\t\t\t20171011205412_B7", "unstructured": "Webley,S.D., Welsh,S.J., Jackman,A.L. and Aherne,G.W. ( 2001 ) The ability to accumulate deoxyuridine triphosphate and cellular response to thymidylate synthase (TS) inhibition. Br. J. Cancer , 85 , 446 \u2013452.", "DOI": "10.1054/bjoc.2001.1921", "doi-asserted-by": "crossref"}, {"key": "key\n\t\t\t\t20171011205412_B8", "unstructured": "Hori,T., Ayusawa,D., Shimizu,K., Koyama,H. and Seno,T. ( 1984 ) Chromosome breakage induced by thymidylate stress in thymidylate synthase-negative mutants of mouse FM3A cells. Cancer Res. , 44 , 703 \u2013709."}, {"key": "key\n\t\t\t\t20171011205412_B9", "unstructured": "Hori,T., Ayusawa,D., Glover,T.W. and Seno,T. ( 1985 ) Expression of fragile site on the human X chromosome in somatic cell hybrids between human fragile X cells and thymidylate synthase-negative mouse mutant cells. Jpn. Cancer Res. , 76 , 977 \u2013983."}, {"key": "key\n\t\t\t\t20171011205412_B10", "unstructured": "Blount,B.C., Mack,M.M., Wehr,C.M., MacGregor,J.T., Hiatt,R.A., Wang,G., Wickramasinghe,S.N., Everson,R.B. and Ames,B.N. ( 1997 ) Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc. Natl Acad. Sci. USA , 94 , 3290 \u20133295.", "DOI": "10.1073/pnas.94.7.3290", "doi-asserted-by": "crossref"}, {"key": "key\n\t\t\t\t20171011205412_B11", "unstructured": "Choi,S.-W. and Mason,J.B. ( 2000 ) Folate and carcinogenesis: an integrated scheme. J. Nutr. , 130 , 129 \u2013132.", "DOI": "10.1093/jn/130.2.129", "doi-asserted-by": "crossref"}, {"key": "key\n\t\t\t\t20171011205412_B12", "unstructured": "Horie,N., Aiba,H., Oguro,K., Hojo,H. and Takeishi,K. ( 1995 ) Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5\u2032-terminal regulatory region of the human gene for thymidylate synthase. Cell Struct. Funct. , 20 , 191 \u2013197.", "DOI": "10.1247/csf.20.191", "doi-asserted-by": "crossref"}, {"key": "key\n\t\t\t\t20171011205412_B13", "unstructured": "Pullarkat,S.T., Stoehlmacher,J., Ghaderi,V., Xiong,Y.-P., Ingles,S.A., Sherrod,A., Warren,R., Tsao-Wei,D., Groshen,S. and Lenz,H.-J. ( 2001 ) Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy. Pharmacogenomics J. , 1 , 65 \u201370.", "DOI": "10.1038/sj.tpj.6500012", "doi-asserted-by": "crossref"}, {"key": "key\n\t\t\t\t20171011205412_B14", "unstructured": "Mandola,M.V., Stoehlmacher,J., Muller-Weeks,S., Cesarone,G., Yu,M.C., Lenz,H.J. and Ladner,R.D. ( 2003 ) A novel single nucleotide polymorphism within the 5\u2032 tandem repeat polymorphism of the thymidylate synthase gene abolishes USF-1 binding and alters transcriptional activity. Cancer Res. , 63 , 2898 \u20132904."}, {"key": "key\n\t\t\t\t20171011205412_B15", "unstructured": "Kawakami,K. and Watanabe,G. Identification and functional analysis of single nucleotide polymorphism in the tandem repeat sequence of thymidylate synthase gene. Cancer Res. , 63 , 6004 \u20136007."}, {"key": "key\n\t\t\t\t20171011205412_B16", "unstructured": "Chen,J., Hunter,D.J., Stampfer,M.J., Kyte,C., Chan,W., Wetmur,J.G., Mosig,R., Selhub,J. and Ma,J. ( 2003 ) Polymorphism in the thymidylate synthase promoter enhancer region modifies the risk and survival of colorectal cancer. Cancer Epidemiol. Biomarkers Prev. , 12 , 958 \u2013962."}, {"key": "key\n\t\t\t\t20171011205412_B17", "unstructured": "Ulrich,C.M., Bigler,J., Bostick,R., Fosdick,L. and Potter,J.D. ( 2002 ) Thymidylate synthase promoter polymorphism, interaction with folate intake, and risk of colorectal adenomas. Cancer Res. , 62 , 3361 \u20133364."}, {"key": "key\n\t\t\t\t20171011205412_B18", "unstructured": "Skibola,C.F., Smith,M.T., Hubbard,A., Shane,B., Roberts,A.C., Law,G.R., Rollinson,S., Roman,E., Cartwright,R.A. and Morgan,G.J. ( 2002 ) Polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia. Blood , 99 , 3786 \u20133791.", "DOI": "10.1182/blood.V99.10.3786", "doi-asserted-by": "crossref"}, {"key": "key\n\t\t\t\t20171011205412_B19", "unstructured": "Hishida,A., Matsuo,K., Hamajima,N., Ito,H., Ogura,M., Kagami,Y., Taji,H., Morishima,Y., Emi,N. and Tajima,K. ( 2003 ) Associations between polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and susceptibility to malignant lymphoma. Haematologica , 88 , 159 \u2013166."}, {"key": "key\n\t\t\t\t20171011205412_B20", "unstructured": "Villafranca,E., Okruzhnov,Y., Domingguez,M.A. et al . ( 2001 ) Polymorphisms of the repeated sequences in the enhancer region of the thymidylate synthase gene promoter may predict downstaging after preoperative chemoradiation in rectal cancer. J. Clin. Oncol. , 19 , 1779 \u20131786.", "DOI": "10.1200/JCO.2001.19.6.1779", "doi-asserted-by": "crossref"}, {"key": "key\n\t\t\t\t20171011205412_B21", "unstructured": "Iacopetta,B., Grieu,F., Joseph,D. and Elsaleh,H. ( 2001 ) A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil. Br. J. Cancer , 85 , 827 \u2013830.", "DOI": "10.1054/bjoc.2001.2007", "doi-asserted-by": "crossref"}, {"key": "key\n\t\t\t\t20171011205412_B22", "unstructured": "Li,J.Y., Ershow,A.G., Chen,Z.J., Wacholder,S., Li,G.Y., Guo,W., Li,B. and Blot,W.J. ( 1989 ) A case\u2013control study of cancer of the esophagus and gastric cardia in Linxian. Int. J. Cancer , 43 , 755 \u2013761.", "DOI": "10.1002/ijc.2910430502", "doi-asserted-by": "crossref"}, {"key": "key\n\t\t\t\t20171011205412_B23", "unstructured": "Chang-Claude,J.C., Wahrendorf,J., Liang,Q.S., Rei,Y.G., Munoz,N., Crespi,M., Raedsch,R., Thurnham,D.I. and Correa,P. ( 1990 ) An epidemiological study of precursor lesions of esophageal cancer among young persons in a high risk population in Huixian, China. Cancer Res. , 50 , 2268 \u20132274."}, {"key": "key\n\t\t\t\t20171011205412_B24", "unstructured": "Guo,W., Blot,W.J., Li,J.Y., Taylor,P.R., Liu,B.Q., Wang,W., Wu,Y.P., Zheng,W., Dawsey,S.M. and Li,B. ( 1994 ) A nested case\u2013control study of esophageal and stomach cancers in the Linxian nutrition intervention trial. Int. J. Epidemiol. , 23 , 444 \u2013450.", "DOI": "10.1093/ije/23.3.444", "doi-asserted-by": "crossref"}, {"key": "key\n\t\t\t\t20171011205412_B25", "unstructured": "Song,C., Xing,D., Tan,W., Wei,Q. and Lin,D. ( 2001 ) Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res. , 61 , 3272 \u20133275."}, {"key": "key\n\t\t\t\t20171011205412_B26", "unstructured": "Miao,X., Xing,D., Tan,W., Qi,J., Lu,W. and Lin,D. ( 2002 ) Susceptibility to gastric cardia adenocarcinoma and genetic polymorphisms in methylenetetrahydrofolate reductase in an at-risk Chinese population. Cancer Epidemiol. Biomarkers Prev. , 11 , 1454 \u20131458."}, {"key": "key\n\t\t\t\t20171011205412_B27", "unstructured": "Shen,H., Xu,Y., Zheng,Y., Qian,Y., Yu,R., Qin,Y., Wang,X., Spitz,M.R. and Wei,Q. ( 2001 ) Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population, a case\u2013control study. Int. J. Cancer , 95 , 332 \u2013336."}, {"key": "key\n\t\t\t\t20171011205412_B28", "unstructured": "Stolzenberg-Solomon,R.Z., Qiao,Y., Abnet,C.C., Ratnasinghe,D.L., Dawsey,S.M., Dong,Z., Taylor,P.R. and Mark,S.D. Esophageal and gastric cardia cancer risk and folate- and vitamin B(12)-related polymorphisms in Linxian, China. Cancer Epidemiol. Biomarkers Prev ., 12 , 1222 \u20131226."}, {"key": "key\n\t\t\t\t20171011205412_B29", "unstructured": "Herbert,V. and Das,K.C. ( 1994 ) Folic acid and vitamin B12. In Shils,M.E., Olson,J.A. and Shike,M. (eds) Modern Nutrition in Health and Disease , 8th edn. , Lea & Febiger, Philadelphia, PA, Vol. 1, pp. 402\u2013425."}, {"key": "key\n\t\t\t\t20171011205412_B30", "unstructured": "Mayne,S.T., Risch,H.A., Dubrow,R. et al . ( 2001 ) Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol. Biomarkers Prev. , 10 , 1055 \u20131062."}, {"key": "key\n\t\t\t\t20171011205412_B31", "unstructured": "Krokan,H.E., Drablos,F. and Slupphaug,G. ( 2002 ) Uracil in DNA\u2014occurrence, consequences and repair. Oncogene , 21 , 8935 \u20138948.", "DOI": "10.1038/sj.onc.1205996", "doi-asserted-by": "crossref"}, {"key": "key\n\t\t\t\t20171011205412_B32", "unstructured": "Guillet,M. and Boiteux,S. ( 2003 ) Origin of endogenous DNA abasic sites in Saccharomyces cerevisiae. Mol. Cell. Biol. , 23 , 8386 \u20138394.", "DOI": "10.1128/MCB.23.22.8386-8394.2003", "doi-asserted-by": "crossref"}, {"key": "key\n\t\t\t\t20171011205412_B33", "unstructured": "Bebenek,K., Roberts,J.D. and Kunkel,T.A. ( 1992 ) The effects of dNTP pool imbalances on frameshift fidelity during DNA replication. J. Biol. Chem. , 267 , 3589 \u20133596."}, {"key": "key\n\t\t\t\t20171011205412_B34", "unstructured": "Melnyk,S., Pogribna,M., Miller,B.J., Basnakian,A.G., Pogribny,I.P. and James,S.J. ( 1999 ) Uracil misincorporation, DNA strand breaks, and gene amplification are associated with tumorigenic cell transformation in folate deficient/repleted Chinese hamster ovary cells. Cancer Lett. , 146 , 35 \u201344.", "DOI": "10.1016/S0304-3835(99)00213-X", "doi-asserted-by": "crossref"}, {"key": "key\n\t\t\t\t20171011205412_B35", "unstructured": "Wei,F., Ni,J., Wu,S.S. et al . ( 2002 ) Cytogenetic studies of esophageal squamous cell carcinomas in the northern Chinese population by comparative genomic hybridization. Cancer Genet. Cytogenet. , 138 , 38 \u201343.", "DOI": "10.1016/S0165-4608(02)00586-1", "doi-asserted-by": "crossref"}, {"key": "key\n\t\t\t\t20171011205412_B36", "unstructured": "Rosenberg,C., Geelen,E., Ijszenga,M.J., Pearson,P., Tanke,H.J., Dinjens,W.N. and van Dekken,H. ( 2002 ) Spectrum of genetic changes in gastro-esophageal cancer cell lines determined by an integrated molecular cytogenetic approach. Cancer Genet. Cytogenet. , 135 , 35 \u201341.", "DOI": "10.1016/S0165-4608(01)00639-2", "doi-asserted-by": "crossref"}, {"key": "key\n\t\t\t\t20171011205412_B37", "unstructured": "Choi,S.W., Kim,Y.I., Weitzel,J.N. and Mason,J.B. ( 1998 ) Folate depletion impairs DNA excision repair in the colon of the rat. Gut , 43 , 93 \u201399.", "DOI": "10.1136/gut.43.1.93", "doi-asserted-by": "crossref"}, {"key": "key\n\t\t\t\t20171011205412_B38", "unstructured": "Wei,Q., Shen,H., Wang,L.-E., Duphorne,C.M., Pillow,P.C., Guo,Z.Z., Qiao,Y. and Spitz,M.R. ( 2003 ) Association between low dietary folate intake and suboptimal cellular DNA repair capacity. Cancer Epidemiol. Biomarkers Prev. , 12 , 963 \u2013969."}, {"key": "key\n\t\t\t\t20171011205412_B39", "unstructured": "Piyathilake,C.J., Macaluso,M., Hine,R.J., Richards,E.W. and Krumdieck,C.L. ( 1994 ) Local and systemic effects of cigarette smoking on folate and vitamin B-12. Am. J. Clin. Nutr. , 60 , 559 \u2013566.", "DOI": "10.1093/ajcn/60.4.559", "doi-asserted-by": "crossref"}, {"key": "key\n\t\t\t\t20171011205412_B40", "unstructured": "Hao,L., Ma,J., Stampfer,M.J., Ren,A., Tian,Y., Tang,Y., Willett,W.C. and Li,Z. ( 2003 ) Geographical, seasonal and gender differences in folate status among Chinese adults. J. Nutr. , 133 , 3630 \u20133635.", "DOI": "10.1093/jn/133.11.3630", "doi-asserted-by": "crossref"}, {"key": "key\n\t\t\t\t20171011205412_B41", "unstructured": "Mannino,D.M., Mulinare,J., Ford,E.S. and Schwartz,J. ( 2003 ) Tobacco smoke exposure and decreased serum and red blood cell folate levels: data from the third National Health and Nutrition Examination Survey. Nicotine. Tob. Res. , 5 , 357 \u2013362.", "DOI": "10.1080/1462220031000094330", "doi-asserted-by": "crossref"}, {"key": "key\n\t\t\t\t20171011205412_B42", "unstructured": "Gao,Y.T., Mclaughlin,J.K., Blot,W.J., Ji,B.T., Benichou,J., Dai,Q. and Fraumeni,J.F.Jr. ( 1994 ) Risk factor for esophageal cancer in Shanghai, China. I. Role of cigarette smoking and alcohol drinking. Int. J. Cancer , 58 , 192 \u2013196.", "DOI": "10.1002/ijc.2910580208", "doi-asserted-by": "crossref"}, {"key": "key\n\t\t\t\t20171011205412_B43", "unstructured": "Engel,L.S., Chow,W.H., Vaughan,T.L. et al . ( 2003 ) Population attributable risks of esophageal and gastric cancers. J. Natl Cancer Inst. , 95 , 1404 \u20131413.", "DOI": "10.1093/jnci/djg047", "doi-asserted-by": "crossref"}, {"key": "key\n\t\t\t\t20171011205412_B44", "unstructured": "Ji,B.T., Chow,W.H., Yang,G., McLaughlin,J.K., Gao,R.N., Zheng,W., Shu,X.O., Jin,F., Fraumeni,J.F.Jr. and Gao,Y.T. ( 1997 ) The influence of cigarette smoking, alcohol, and green tea consumption on the risk of carcinoma of the cardia and distal stomach in Shanghai, China. Cancer , 77 , 2449 \u20132457.", "DOI": "10.1002/(SICI)1097-0142(19960615)77:12<2449::AID-CNCR6>3.0.CO;2-H", "doi-asserted-by": "crossref"}, {"key": "key\n\t\t\t\t20171011205412_B45", "unstructured": "Shi,Q., Zhang,Z., Neumann,A.S., Li,G., Spitz,M.R. and Wei,Q. ( 2005 ) Case\u2013control analysis of thymidylate synthase polymorphisms and risk of lung cancer. Carcinogenesis , 26 , 649 \u2013656.", "DOI": "10.1093/carcin/bgh351", "doi-asserted-by": "crossref"}, {"key": "key\n\t\t\t\t20171011205412_B46", "unstructured": "Zhang,J., Cui,Y., Kuang,G. et al . ( 2004 ) Association of the thymidylate synthase polymorphisms with esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma. Carcinogenesis , 25 , 2479 \u20132485.", "DOI": "10.1093/carcin/bgh247", "doi-asserted-by": "crossref"}], "container-title": ["Carcinogenesis"], "language": "en", "link": [{"URL": "http://academic.oup.com/carcin/article-pdf/26/8/1430/7089374/bgi090.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 2, 10]], "date-time": "2019-02-10T06:37:22Z", "timestamp": 1549780642000}, "score": 30.871317, "issued": {"date-parts": [[2005, 4, 7]]}, "references-count": 46, "journal-issue": {"published-online": {"date-parts": [[2005, 4, 7]]}, "published-print": {"date-parts": [[2005, 8, 1]]}, "issue": "8"}, "URL": "http://dx.doi.org/10.1093/carcin/bgi090", "relation": {"cites": []}, "ISSN": ["1460-2180", "0143-3334"], "issn-type": [{"value": "0143-3334", "type": "print"}, {"value": "1460-2180", "type": "electronic"}], "subject": ["Cancer Research", "General Medicine"]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T08:48:43Z", "timestamp": 1574326123957}, "reference-count": 0, "publisher": "Ferrata Storti Foundation (Haematologica)", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Haematologica"], "published-print": {"date-parts": [[2007, 3, 1]]}, "DOI": "10.3324/haematol.10752", "type": "journal-article", "created": {"date-parts": [[2007, 10, 18]], "date-time": "2007-10-18T20:05:54Z", "timestamp": 1192737954000}, "page": "308-314", "source": "Crossref", "is-referenced-by-count": 45, "title": ["The potential effect of gender in combination with common genetic polymorphisms of drug-metabolizing enzymes on the risk of developing acute leukemia"], "prefix": "10.3324", "volume": "92", "author": [{"given": "P.", "family": "Bolufer", "sequence": "first", "affiliation": []}, {"given": "M.", "family": "Collado", "sequence": "additional", "affiliation": []}, {"given": "E.", "family": "Barragan", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Cervera", "sequence": "additional", "affiliation": []}, {"given": "M.-J.", "family": "Calasanz", "sequence": "additional", "affiliation": []}, {"given": "D.", "family": "Colomer", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Roman-Gomez", "sequence": "additional", "affiliation": []}, {"given": "M. A.", "family": "Sanz", "sequence": "additional", "affiliation": []}], "member": "1856", "container-title": ["Haematologica"], "language": "en", "deposited": {"date-parts": [[2011, 6, 25]], "date-time": "2011-06-25T20:10:00Z", "timestamp": 1309032600000}, "score": 30.343575, "issued": {"date-parts": [[2007, 3, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2007, 3, 1]]}, "issue": "3"}, "URL": "http://dx.doi.org/10.3324/haematol.10752", "ISSN": ["0390-6078", "1592-8721"], "issn-type": [{"value": "0390-6078", "type": "print"}, {"value": "1592-8721", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T01:20:32Z", "timestamp": 1574299232525}, "reference-count": 130, "publisher": "Springer Science and Business Media LLC", "issue": "1", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2007, 6, 5]], "date-time": "2007-06-05T00:00:00Z", "timestamp": 1181001600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Pharmacogenomics J"], "published-print": {"date-parts": [[2008, 2]]}, "DOI": "10.1038/sj.tpj.6500462", "type": "journal-article", "created": {"date-parts": [[2007, 6, 12]], "date-time": "2007-06-12T10:20:39Z", "timestamp": 1181643639000}, "page": "4-15", "source": "Crossref", "is-referenced-by-count": 70, "title": ["The clinical role of genetic polymorphisms in drug-metabolizing enzymes"], "prefix": "10.1038", "volume": "8", "author": [{"given": "D", "family": "Tomalik-Scharte", "sequence": "first", "affiliation": []}, {"given": "A", "family": "Lazar", "sequence": "additional", "affiliation": []}, {"given": "U", "family": "Fuhr", "sequence": "additional", "affiliation": []}, {"given": "J", "family": "Kirchheiner", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2007, 6, 5]]}, "reference": [{"key": "BF6500462_CR1", "doi-asserted-by": "publisher", "first-page": "1340", "DOI": "10.1007/s00115-005-1915-8", "volume": "76", "author": "J Kirchheiner", "year": "2005", "unstructured": "Kirchheiner J, Sasse J, Roots I, Brockmoller J, Bauer M . The value of pharmacogenetic tests in antidepressive medication therapy. Nervenarzt 2005; 76: 1340\u20131354.", "journal-title": "Nervenarzt"}, {"key": "BF6500462_CR2", "doi-asserted-by": "publisher", "first-page": "75", "DOI": "10.1176/appi.psy.47.1.75", "volume": "47", "author": "J de Leon", "year": "2006", "unstructured": "de Leon J, Armstrong SC, Cozza KL . Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19. Psychosomatics 2006; 47: 75\u201385.", "journal-title": "Psychosomatics"}, {"key": "BF6500462_CR3", "doi-asserted-by": "publisher", "first-page": "576", "DOI": "10.1016/S0140-6736(56)92065-7", "volume": "2", "author": "W Kalow", "year": "1956", "unstructured": "Kalow W . Familial incidence of low pseudocholinesterase level. Lancet 1956; 2: 576\u2013577.", "journal-title": "Lancet"}, {"key": "BF6500462_CR4", "doi-asserted-by": "publisher", "first-page": "5", "DOI": "10.3109/15622970209150599", "volume": "3", "author": "M Bauer", "year": "2002", "unstructured": "Bauer M, Whybrow PC, Angst J, Versiani M, Moller HJ . World federation of societies of biological psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders part 1: acute and continuation treatment of major depressive disorder. World J Biol Psychiatry 2002; 3: 5\u201343.", "journal-title": "World J Biol Psychiatry"}, {"issue": "Suppl 1", "key": "BF6500462_CR5", "first-page": "5", "volume": "64", "author": "JC Nelson", "year": "2003", "unstructured": "Nelson JC . Managing treatment-resistant major depression. J Clin Psychiatry 2003; 64 (Suppl 1): 5\u201312.", "journal-title": "J Clin Psychiatry"}, {"key": "BF6500462_CR6", "doi-asserted-by": "publisher", "first-page": "102", "DOI": "10.1097/00004850-198604000-00002", "volume": "1", "author": "P Baumann", "year": "1986", "unstructured": "Baumann P, Jonzier Perey M, Koeb L, K\u00fcpfer A, Tinguely D, Schopf J . Amitriptyline pharmacokinetics and clinical response: II. Metabolic polymorphism assessed by hydroxylation of debrisoquine and mephenytoin. Int Clin Psychopharmacol 1986; 1: 102\u2013112.", "journal-title": "Int Clin Psychopharmacol"}, {"key": "BF6500462_CR7", "doi-asserted-by": "publisher", "first-page": "111", "DOI": "10.1046/j.0306-5251.2001.01548.x", "volume": "53", "author": "L Bertilsson", "year": "2002", "unstructured": "Bertilsson L, Dahl ML, Dalen P, Al-Shurbaji A . Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs. Br J Clin Pharmacol 2002; 53: 111\u2013122.", "journal-title": "Br J Clin Pharmacol"}, {"key": "BF6500462_CR8", "first-page": "284", "volume": "60", "author": "C Sachse", "year": "1997", "unstructured": "Sachse C, Brockmoller J, Bauer S, Roots I . Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences. Am J Hum Genet 1997; 60: 284\u2013295.", "journal-title": "Am J Hum Genet"}, {"key": "BF6500462_CR9", "doi-asserted-by": "publisher", "first-page": "573", "DOI": "10.1097/00008571-200110000-00004", "volume": "11", "author": "UM Zanger", "year": "2001", "unstructured": "Zanger UM, Fischer J, Raimundo S, Stuven T, Evert BO, Schwab M et al. Comprehensive analysis of the genetic factors determining expression and function of hepatic CYP2D6. Pharmacogenetics 2001; 11: 573\u2013585.", "journal-title": "Pharmacogenetics"}, {"key": "BF6500462_CR10", "doi-asserted-by": "publisher", "first-page": "15", "DOI": "10.1097/00008571-199802000-00003", "volume": "8", "author": "EU Griese", "year": "1998", "unstructured": "Griese EU, Zanger UM, Brudermanns U, Gaedigk A, Mikus G, Morike K et al. Assessment of the predictive power of genotypes for the in-vivo catalytic function of CYP2D6 in a German population. Pharmacogenetics 1998; 8: 15\u201326.", "journal-title": "Pharmacogenetics"}, {"key": "BF6500462_CR11", "doi-asserted-by": "publisher", "first-page": "442", "DOI": "10.1038/sj.mp.4001494", "volume": "9", "author": "J Kirchheiner", "year": "2004", "unstructured": "Kirchheiner J, Nickchen K, Bauer M, Wong ML, Licinio J, Roots I et al. Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response. Mol Psychiatry 2004; 9: 442\u2013473.", "journal-title": "Mol Psychiatry"}, {"key": "BF6500462_CR12", "doi-asserted-by": "publisher", "first-page": "5", "DOI": "10.2515/therapie:2004003", "volume": "59", "author": "K Brosen", "year": "2004", "unstructured": "Brosen K . Some aspects of genetic polymorphism in the biotransformation of antidepressants. Therapie 2004; 59: 5\u201312.", "journal-title": "Therapie"}, {"key": "BF6500462_CR13", "doi-asserted-by": "publisher", "first-page": "1001", "DOI": "10.1592/phco.22.12.1001.33603", "volume": "22", "author": "YW Lam", "year": "2002", "unstructured": "Lam YW, Gaedigk A, Ereshefsky L, Alfaro CL, Simpson J . CYP2D6 inhibition by selective serotonin reuptake inhibitors: analysis of achievable steady-state plasma concentrations and the effect of ultrarapid metabolism at CYP2D6. Pharmacotherapy 2002; 22: 1001\u20131006.", "journal-title": "Pharmacotherapy"}, {"key": "BF6500462_CR14", "doi-asserted-by": "publisher", "first-page": "327", "DOI": "10.1016/S0009-9236(01)21861-X", "volume": "70", "author": "K Laine", "year": "2001", "unstructured": "Laine K, Tybring G, Hartter S, Andersson K, Svensson JO, Widen J et al. Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test. Clin Pharmacol Ther 2001; 70: 327\u2013335.", "journal-title": "Clin Pharmacol Ther"}, {"key": "BF6500462_CR15", "doi-asserted-by": "publisher", "first-page": "129", "DOI": "10.1007/s002280050261", "volume": "52", "author": "O Spigset", "year": "1997", "unstructured": "Spigset O, Granberg K, Hagg S, Norstrom A, Dahlqvist R . Relationship between fluvoxamine pharmacokinetics and CYP2D6/CYP2C19 phenotype polymorphisms. Eur J Clin Pharmacol 1997; 52: 129\u2013133.", "journal-title": "Eur J Clin Pharmacol"}, {"key": "BF6500462_CR16", "doi-asserted-by": "publisher", "first-page": "183", "DOI": "10.1016/S0009-9236(96)90134-4", "volume": "60", "author": "JA Carrillo", "year": "1996", "unstructured": "Carrillo JA, Dahl ML, Svensson JO, Alm C, Rodriguez I, Bertilsson L . Disposition of fluvoxamine in humans is determined by the polymorphic CYP2D6 and also by the CYP1A2 activity. Clin Pharmacol Ther 1996; 60: 183\u2013190.", "journal-title": "Clin Pharmacol Ther"}, {"key": "BF6500462_CR17", "doi-asserted-by": "publisher", "first-page": "257", "DOI": "10.1046/j.1365-2125.1998.00670.x", "volume": "45", "author": "O Spigset", "year": "1998", "unstructured": "Spigset O, Granberg K, Hagg S, Soderstrom E, Dahlqvist R . Non-linear fluvoxamine disposition. Br J Clin Pharmacol 1998; 45: 257\u2013263.", "journal-title": "Br J Clin Pharmacol"}, {"key": "BF6500462_CR18", "doi-asserted-by": "publisher", "first-page": "330", "DOI": "10.1097/00004714-200106000-00013", "volume": "21", "author": "CB Eap", "year": "2001", "unstructured": "Eap CB, Bondolfi G, Zullino D, Savary-Cosendai L, Powell-Golay K, Kosel M et al. Concentrations of the enantiomers of fluoxetine and norfluoxetine after multiple doses of fluoxetine in cytochrome P4502D6 poor and extensive metabolizers. J Clin Psychopharmacol 2001; 21: 330\u2013334.", "journal-title": "J Clin Psychopharmacol"}, {"key": "BF6500462_CR19", "doi-asserted-by": "publisher", "first-page": "997", "DOI": "10.1016/0028-3908(92)90100-4", "volume": "31", "author": "RW Fuller", "year": "1992", "unstructured": "Fuller RW, Snoddy HD, Krushinski JH, Robertson DW . Comparison of norfluoxetine enantiomers as serotonin uptake inhibitors in vivo. Neuropharmacology 1992; 31: 997\u20131000.", "journal-title": "Neuropharmacology"}, {"key": "BF6500462_CR20", "doi-asserted-by": "publisher", "first-page": "288", "DOI": "10.1038/clpt.1992.24", "volume": "1", "author": "SH Sindrup", "year": "1992", "unstructured": "Sindrup SH, Br\u00f8sen K, Gram LF . Pharmacokinetics of the selective serotonin reuptake inhibitor paroxetine: nonlinearity and relation to the sparteine oxidation polymorphism. Clin Pharmacol Ther 1992; 1: 288\u2013295.", "journal-title": "Clin Pharmacol Ther"}, {"key": "BF6500462_CR21", "doi-asserted-by": "publisher", "first-page": "647", "DOI": "10.1097/01.jcp.0000145341.30547.f0", "volume": "24", "author": "J Kirchheiner", "year": "2004", "unstructured": "Kirchheiner J, Henckel HB, Meineke I, Roots I, Brockm\u00f6ller J . Impact of the CYP2D6 ultra-rapid metabolizer genotype on mirtazapine pharmacokinetics and adverse events in healthy volunteers. J Clin Psychopharmacol 2004; 24: 647\u2013652.", "journal-title": "J Clin Psychopharmacol"}, {"key": "BF6500462_CR22", "doi-asserted-by": "publisher", "first-page": "149", "DOI": "10.1111/j.1365-2125.1996.tb00173.x", "volume": "41", "author": "SV Otton", "year": "1996", "unstructured": "Otton SV, Ball SE, Cheung SW, Inaba T, Rudolph RL, Sellers EM . Venlafaxine oxidation in vitro is catalysed by CYP2D6. Br J Clin Pharmacol 1996; 41: 149\u2013156.", "journal-title": "Br J Clin Pharmacol"}, {"key": "BF6500462_CR23", "doi-asserted-by": "publisher", "first-page": "450", "DOI": "10.1046/j.1365-2125.1999.00913.x", "volume": "47", "author": "T Fukuda", "year": "1999", "unstructured": "Fukuda T, Yamamoto I, Nishida Y, Zhou Q, Ohno M, Takada K et al. Effect of the CYP2D6*10 genotype on venlafaxine pharmacokinetics in healthy adult volunteers. Br J Clin Pharmacol 1999; 47: 450\u2013453.", "journal-title": "Br J Clin Pharmacol"}, {"key": "BF6500462_CR24", "doi-asserted-by": "publisher", "first-page": "202", "DOI": "10.1097/00007691-200004000-00011", "volume": "22", "author": "AH Veefkind", "year": "2000", "unstructured": "Veefkind AH, Haffmans PM, Hoencamp E . Venlafaxine serum levels and CYP2D6 genotype. Ther Drug Monit 2000; 22: 202\u2013208.", "journal-title": "Ther Drug Monit"}, {"key": "BF6500462_CR25", "doi-asserted-by": "publisher", "first-page": "383", "DOI": "10.1111/j.1365-2125.1994.tb04293.x", "volume": "37", "author": "L Firkusny", "year": "1994", "unstructured": "Firkusny L, Gleiter CH . Maprotiline metabolism appears to co-segregate with the genetically-determined CYP2D6 polymorphic hydroxylation of debrisoquine. Br J Clin Pharmacol 1994; 37: 383\u2013388.", "journal-title": "Br J Clin Pharmacol"}, {"key": "BF6500462_CR26", "doi-asserted-by": "publisher", "first-page": "409", "DOI": "10.1016/0006-2952(85)90063-2", "volume": "34", "author": "G Gabris", "year": "1985", "unstructured": "Gabris G, Baumann P, Janzier-perey MPB, Woggon B, K\u00fcpfer A . N-methylation of maprotiline in debrisoquine/mephenytoin-phenotyped depressive patients. Biochemical Pharmacology 1985; 34: 409\u2013410.", "journal-title": "Biochemical Pharmacology"}, {"key": "BF6500462_CR27", "first-page": "1222", "volume": "28", "author": "SR Faucette", "year": "2000", "unstructured": "Faucette SR, Hawke RL, Lecluyse EL, Shord SS, Yan B, Laethem RM et al. Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity. Drug Metab Dispos 2000; 28: 1222\u20131230.", "journal-title": "Drug Metab Dispos"}, {"key": "BF6500462_CR28", "doi-asserted-by": "publisher", "first-page": "573", "DOI": "10.1111/j.1365-2125.1996.tb00051.x", "volume": "42", "author": "RH Barbhaiya", "year": "1996", "unstructured": "Barbhaiya RH, Buch AB, Greene DS . Single and multiple dose pharmacokinetics of nefazodone in subjects classified as extensive and poor metabolizers of dextromethorphan. Br J Clin Pharmacol 1996; 42: 573\u2013581.", "journal-title": "Br J Clin Pharmacol"}, {"issue": "Suppl 1", "key": "BF6500462_CR29", "doi-asserted-by": "publisher", "first-page": "S23", "DOI": "10.1016/S0924-977X(97)00417-3", "volume": "7", "author": "P Dostert", "year": "1997", "unstructured": "Dostert P, Benedetti MS, Poggesi I . Review of the pharmacokinetics and metabolism of reboxetine, a selective noradrenaline reuptake inhibitor. Eur Neuropsychopharmacol 1997; 7 (Suppl 1): S23\u2013S35; discussion S71\u2013S73.", "journal-title": "Eur Neuropsychopharmacol"}, {"key": "BF6500462_CR30", "doi-asserted-by": "publisher", "first-page": "98", "DOI": "10.1111/j.1600-0447.1990.tb05347.x", "volume": "360", "author": "MP Schoerlin", "year": "1990", "unstructured": "Schoerlin MP, Blouin RA, Pfefen JP, Guentert TW . Comparison of the pharmacokinetics of moclobemide in poor and efficient metabolizers of debrisoquine. Acta Psychiatr Scand Suppl 1990; 360: 98\u2013100.", "journal-title": "Acta Psychiatr Scand Suppl"}, {"key": "BF6500462_CR31", "doi-asserted-by": "publisher", "first-page": "225", "DOI": "10.1016/0924-977X(96)00023-5", "volume": "6", "author": "S H\u00e4rtter", "year": "1996", "unstructured": "H\u00e4rtter S, Dingemanse J, Baier D, Ziegler G, Hiemke C . The role of cytochrome P450 2D6 in the metabolism of moclobemide. Eur Neuropsychopharmacol 1996; 6: 225\u2013230.", "journal-title": "Eur Neuropsychopharmacol"}, {"key": "BF6500462_CR32", "doi-asserted-by": "publisher", "first-page": "670", "DOI": "10.1016/0009-9236(95)90230-9", "volume": "57", "author": "LF Gram", "year": "1995", "unstructured": "Gram LF, Guentert TW, Grange S, Vistisen K, Br\u00f8sen K . Moclobemide, a substrate of CYP2C19 and an inhibitor of CYP2C19, CYP2D6, and CYP1A2: a panel study. Clin Pharmacol Ther 1995; 57: 670\u2013677.", "journal-title": "Clin Pharmacol Ther"}, {"key": "BF6500462_CR33", "doi-asserted-by": "publisher", "first-page": "95", "DOI": "10.1007/s002130050376", "volume": "133", "author": "K Mihara", "year": "1997", "unstructured": "Mihara K, Otani K, Suzuki A, Yasui N, Nakano H, Meng X et al. Relationship between the CYP2D6 genotype and the steady-state plasma concentrations of trazodone and its active metabolite m-chlorophenylpiperazine. Psychopharmacology (Berl) 1997; 133: 95\u201398.", "journal-title": "Psychopharmacology (Berl)"}, {"key": "BF6500462_CR34", "doi-asserted-by": "publisher", "first-page": "386", "DOI": "10.1016/j.clpt.2003.12.015", "volume": "75", "author": "T Rau", "year": "2004", "unstructured": "Rau T, Wohlleben G, Wuttke H, Thuerauf N, Lunkenheimer J, Lanczik M et al. CYP2D6 genotype: impact on adverse effects and nonresponse during treatment with antidepressants-a pilot study. Clin Pharmacol Ther 2004; 75: 386\u2013393.", "journal-title": "Clin Pharmacol Ther"}, {"key": "BF6500462_CR35", "first-page": "329", "volume": "60", "author": "K Grasmader", "year": "2004", "unstructured": "Grasmader K, Verwohlt PL, Rietschel M, Dragicevic A, Muller M, Hiemke C et al. Impact of polymorphisms of cytochrome-P450 isoenzymes 2C9, 2C19 and 2D6 on plasma concentrations and clinical effects of antidepressants in a naturalistic clinical setting. Eur J Clin Pharmacol 2004; 60: 329\u2013336.", "journal-title": "Eur J Clin Pharmacol"}, {"key": "BF6500462_CR36", "doi-asserted-by": "publisher", "first-page": "435", "DOI": "10.1097/00008571-199912000-00003", "volume": "9", "author": "E Lessard", "year": "1999", "unstructured": "Lessard E, Yessine M, Hamelin B, O\u2019Hara G, LeBlanc J, Turgeon J . Influence of CYP2D6 activity on the disposition and cardiovascular toxicity of the antidepressant agent venlafaxine in humans. Pharmacogenetics 1999; 9: 435\u2013443.", "journal-title": "Pharmacogenetics"}, {"key": "BF6500462_CR37", "doi-asserted-by": "publisher", "first-page": "522", "DOI": "10.1016/S0009-9236(96)90148-4", "volume": "60", "author": "S Chen", "year": "1996", "unstructured": "Chen S, Chou WH, Blouin RA, Mao Z, Humphries LL, Meek QC et al. The cytochrome P450 2D6 (CYP2D6) enzyme polymorphism: screening costs and influence on clinical outcomes in psychiatry. Clin Pharmacol Ther 1996; 60: 522\u2013534.", "journal-title": "Clin Pharmacol Ther"}, {"key": "BF6500462_CR38", "doi-asserted-by": "publisher", "first-page": "173", "DOI": "10.1034/j.1600-0447.2001.00299.x", "volume": "104", "author": "J Kirchheiner", "year": "2001", "unstructured": "Kirchheiner J, Brosen K, Dahl ML, Gram LF, Kasper S, Roots I et al. CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: a first step towards subpopulation-specific dosages. Acta Psychiatr Scand 2001; 104: 173\u2013192.", "journal-title": "Acta Psychiatr Scand"}, {"key": "BF6500462_CR39", "doi-asserted-by": "publisher", "first-page": "301", "DOI": "10.1111/j.1365-2125.1982.tb01982.x", "volume": "14", "author": "MS Lennard", "year": "1982", "unstructured": "Lennard MS, Silas JH, Freestone S, Trevethick J . Defective metabolism of metoprolol in poor hydroxylators of debrisoquine. Br J Clin Pharmacol 1982; 14: 301\u2013303.", "journal-title": "Br J Clin Pharmacol"}, {"key": "BF6500462_CR40", "doi-asserted-by": "publisher", "first-page": "732", "DOI": "10.1038/clpt.1983.242", "volume": "34", "author": "MS Lennard", "year": "1983", "unstructured": "Lennard MS, Tucker GT, Silas JH, Freestone S, Ramsay LE, Woods HF . Differential stereoselective metabolism of metoprolol in extensive and poor debrisoquin metabolizers. Clin Pharmacol Ther 1983; 34: 732\u2013737.", "journal-title": "Clin Pharmacol Ther"}, {"key": "BF6500462_CR41", "doi-asserted-by": "publisher", "first-page": "469", "DOI": "10.1007/s002280050495", "volume": "54", "author": "R Koytchev", "year": "1998", "unstructured": "Koytchev R, Alken RG, Vlahov V, Kirkov V, Kaneva R, Thyroff Friesinger U et al. Influence of the cytochrome P4502D6*4 allele on the pharmacokinetics of controlled-release metoprolol. Eur J Clin Pharmacol 1998; 54: 469\u2013474.", "journal-title": "Eur J Clin Pharmacol"}, {"key": "BF6500462_CR42", "doi-asserted-by": "publisher", "first-page": "555", "DOI": "10.1111/j.1365-2125.1985.tb05112.x", "volume": "20", "author": "JC McGourty", "year": "1985", "unstructured": "McGourty JC, Silas JH, Lennard MS, Tucker GT, Woods HF . Metoprolol metabolism and debrisoquine oxidation polymorphism--population and family studies. Br J Clin Pharmacol 1985; 20: 555\u2013566.", "journal-title": "Br J Clin Pharmacol"}, {"key": "BF6500462_CR43", "doi-asserted-by": "publisher", "first-page": "1558", "DOI": "10.1056/NEJM198212163072505", "volume": "307", "author": "MS Lennard", "year": "1982", "unstructured": "Lennard MS, Silas JH, Freestone S, Ramsay LE, Tucker GT, Woods HF . Oxidation phenotype \u2013 a major determinant of metoprolol metabolism and response. N Engl J Med 1982; 307: 1558\u20131560.", "journal-title": "N Engl J Med"}, {"key": "BF6500462_CR44", "doi-asserted-by": "publisher", "first-page": "302", "DOI": "10.1016/j.clpt.2004.07.002", "volume": "76", "author": "J Kirchheiner", "year": "2004", "unstructured": "Kirchheiner J, Heesch C, Bauer S, Meisel C, Seringer A, Goldammer M et al. Impact of the ultrarapid metabolizer genotype of cytochrome P450 2D6 on metoprolol pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther 2004; 76: 302\u2013312.", "journal-title": "Clin Pharmacol Ther"}, {"key": "BF6500462_CR45", "doi-asserted-by": "publisher", "first-page": "108", "DOI": "10.1007/BF01409476", "volume": "38", "author": "G Neugebauer", "year": "1990", "unstructured": "Neugebauer G, Akpan W, Kaufmann B, Reiff K . Stereoselective disposition of carvedilol in man after intravenous and oral administration of the racemic compound. Eur J Clin Pharmacol 1990; 38: 108\u2013111.", "journal-title": "Eur J Clin Pharmacol"}, {"key": "BF6500462_CR46", "first-page": "970", "volume": "25", "author": "HG Oldham", "year": "1997", "unstructured": "Oldham HG, Clarke SE . In vitro identification of the human cytochrome P450 enzymes involved in the metabolism of R(+)- and S(\u2212)-carvedilol. Drug Metab Dispos 1997; 25: 970\u2013977.", "journal-title": "Drug Metab Dispos"}, {"key": "BF6500462_CR47", "doi-asserted-by": "publisher", "first-page": "518", "DOI": "10.1016/0009-9236(95)90036-5", "volume": "57", "author": "HH Zhou", "year": "1995", "unstructured": "Zhou HH, Wood AJJ . Stereoselective disposition of carvedilol is determined by CYP2D6. Clin Pharmacol Ther 1995; 57: 518\u2013524.", "journal-title": "Clin Pharmacol Ther"}, {"key": "BF6500462_CR48", "doi-asserted-by": "publisher", "first-page": "97", "DOI": "10.1177/00912700122009746", "volume": "41", "author": "DW Graff", "year": "2001", "unstructured": "Graff DW, Williamson KM, Pieper JA, Carson SW, Adams Jr KF, Cascio WE et al. Effect of fluoxetine on carvedilol pharmacokinetics, CYP2D6 activity, and autonomic balance in heart failure patients. J Clin Pharmacol 2001; 41: 97\u2013106.", "journal-title": "J Clin Pharmacol"}, {"key": "BF6500462_CR49", "doi-asserted-by": "publisher", "first-page": "101", "DOI": "10.1097/00008571-200203000-00004", "volume": "12", "author": "J Kirchheiner", "year": "2002", "unstructured": "Kirchheiner J, Bauer S, Meineke I, Rohde W, Prang V, Meisel C et al. Impact of CYP2C9 and CYP2C19 polymorphisms on tolbutamide kinetics and the insulin and glucose response in healthy volunteers. Pharmacogenetics 2002; 12: 101\u2013109.", "journal-title": "Pharmacogenetics"}, {"key": "BF6500462_CR50", "first-page": "207", "volume": "23", "author": "RA Stearns", "year": "1995", "unstructured": "Stearns RA, Chakravarty PK, Chen R, Chiu SH . Biotransformation of losartan to its active carboxylic acid metabolite in human liver microsomes. Role of cytochrome P4502C and 3A subfamily members. Drug Metab Dispos 1995; 23: 207\u2013215.", "journal-title": "Drug Metab Dispos"}, {"key": "BF6500462_CR51", "doi-asserted-by": "publisher", "first-page": "348", "DOI": "10.1016/S0009-9236(99)70114-1", "volume": "65", "author": "JB McCrea", "year": "1999", "unstructured": "McCrea JB, Cribb A, Rushmore T, Osborne B, Gillen L, Lo MW et al. Phenotypic and genotypic investigations of a healthy volunteer deficient in the conversion of losartan to its active metabolite E-31. Clin Pharmacol Ther 1999; 65: 348\u2013352.", "journal-title": "Clin Pharmacol Ther"}, {"key": "BF6500462_CR52", "doi-asserted-by": "publisher", "first-page": "89", "DOI": "10.1067/mcp.2002.121216", "volume": "71", "author": "U Yasar", "year": "2002", "unstructured": "Yasar U, Forslund-Bergengren C, Tybring G, Dorado P, Llerena A, Sjoqvist F et al. Pharmacokinetics of losartan and its metabolite E-3174 in relation to the CYP2C9 genotype. Clin Pharmacol Ther 2002; 71: 89\u201398.", "journal-title": "Clin Pharmacol Ther"}, {"key": "BF6500462_CR53", "doi-asserted-by": "publisher", "first-page": "84", "DOI": "10.1177/0091270002239710", "volume": "43", "author": "CR Lee", "year": "2003", "unstructured": "Lee CR, Pieper JA, Frye RF, Hinderliter AL, Blaisdell JA, Goldstein JA . Tolbutamide, flurbiprofen, and losartan as probes of CYP2C9 activity in humans. J Clin Pharmacol 2003; 43: 84\u201391.", "journal-title": "J Clin Pharmacol"}, {"key": "BF6500462_CR54", "doi-asserted-by": "publisher", "first-page": "2089", "DOI": "10.1097/00004872-200210000-00030", "volume": "20", "author": "P Hallberg", "year": "2002", "unstructured": "Hallberg P, Karlsson J, Kurland L, Lind L, Kahan T, Malmqvist K et al. The CYP2C9 genotype predicts the blood pressure response to irbesartan: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (S0ILVHIA) trial. J Hypertens 2002; 20: 2089\u20132093.", "journal-title": "J Hypertens"}, {"key": "BF6500462_CR55", "doi-asserted-by": "publisher", "first-page": "505", "DOI": "10.1016/j.clpt.2003.08.001", "volume": "74", "author": "S Uchida", "year": "2003", "unstructured": "Uchida S, Watanabe H, Nishio S, Hashimoto H, Yamazaki K, Hayashi H et al. Altered pharmacokinetics and excessive hypotensive effect of candesartan in a patient with the CYP2C91/3 genotype. Clin Pharmacol Ther 2003; 74: 505\u2013508.", "journal-title": "Clin Pharmacol Ther"}, {"key": "BF6500462_CR56", "first-page": "1360", "volume": "128", "author": "DM Adcock", "year": "2004", "unstructured": "Adcock DM, Koftan C, Crisan D, Kiechle FL . Effect of polymorphisms in the cytochrome P450 CYP2C9 gene on warfarin anticoagulation. Arch Pathol Lab Med 2004; 128: 1360\u20131363.", "journal-title": "Arch Pathol Lab Med"}, {"key": "BF6500462_CR57", "doi-asserted-by": "publisher", "first-page": "525", "DOI": "10.1046/j.1365-2125.1998.00721.x", "volume": "45", "author": "JO Miners", "year": "1998", "unstructured": "Miners JO, Birkett DJ . Cytochrome P4502C9: an enzyme of major importance in human drug metabolism. Br J Clin Pharmacol 1998; 45: 525\u2013538.", "journal-title": "Br J Clin Pharmacol"}, {"key": "BF6500462_CR58", "doi-asserted-by": "publisher", "first-page": "702", "DOI": "10.1067/mcp.2002.129321", "volume": "72", "author": "MG Scordo", "year": "2002", "unstructured": "Scordo MG, Pengo V, Spina E, Dahl ML, Gusella M, Padrini R . Influence of CYP2C9 and CYP2C19 genetic polymorphisms on warfarin maintenance dose and metabolic clearance. Clin Pharmacol Ther 2002; 72: 702\u2013710.", "journal-title": "Clin Pharmacol Ther"}, {"key": "BF6500462_CR59", "doi-asserted-by": "publisher", "first-page": "1690", "DOI": "10.1001/jama.287.13.1690", "volume": "287", "author": "MK Higashi", "year": "2002", "unstructured": "Higashi MK, Veenstra DL, Kondo LM, Wittkowsky AK, Srinouanprachanh SL, Farin FM et al. Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy. JAMA 2002; 287: 1690\u20131698.", "journal-title": "JAMA"}, {"key": "BF6500462_CR60", "doi-asserted-by": "publisher", "first-page": "717", "DOI": "10.1016/S0140-6736(98)04474-2", "volume": "353", "author": "GP Aithal", "year": "1999", "unstructured": "Aithal GP, Day CP, Kesteven PJ, Daly AK . Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications. Lancet 1999; 353: 717\u2013719.", "journal-title": "Lancet"}, {"key": "BF6500462_CR61", "doi-asserted-by": "publisher", "first-page": "376", "DOI": "10.1016/j.clpt.2004.01.007", "volume": "75", "author": "H Takahashi", "year": "2004", "unstructured": "Takahashi H, Wilkinson GR, Padrini R, Echizen H . CYP2C9 and oral anticoagulation therapy with acenocoumarol and warfarin:similarities yet differences. Clin Pharmacol Ther 2004; 75: 376\u2013380.", "journal-title": "Clin Pharmacol Ther"}, {"key": "BF6500462_CR62", "doi-asserted-by": "publisher", "first-page": "403", "DOI": "10.1016/j.clpt.2004.01.008", "volume": "75", "author": "S Morin", "year": "2004", "unstructured": "Morin S, Bodin L, Loriot MA, Thijssen HH, Robert A, Strabach S et al. Pharmacogenetics of acenocoumarol pharmacodynamics. Clin Pharmacol Ther 2004; 75: 403\u2013414.", "journal-title": "Clin Pharmacol Ther"}, {"key": "BF6500462_CR63", "doi-asserted-by": "publisher", "first-page": "394", "DOI": "10.1016/j.clpt.2003.12.017", "volume": "75", "author": "T Schalekamp", "year": "2004", "unstructured": "Schalekamp T, van Geest-Daalderop JH, de Vries-Goldschmeding H, Conemans J, Bernsen MjM, de Boer A . Acenocoumarol stabilization is delayed in CYP2C93 carriers. Clin Pharmacol Ther 2004; 75: 394\u2013402.", "journal-title": "Clin Pharmacol Ther"}, {"key": "BF6500462_CR64", "doi-asserted-by": "publisher", "first-page": "27", "DOI": "10.1097/00008571-200401000-00003", "volume": "14", "author": "LE Visser", "year": "2004", "unstructured": "Visser LE, van Vliet M, van Schaik RH, Kasbergen AA, De Smet PA, Vulto AG et al. The risk of overanticoagulation in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon. Pharmacogenetics 2004; 14: 27\u201333.", "journal-title": "Pharmacogenetics"}, {"key": "BF6500462_CR65", "doi-asserted-by": "publisher", "first-page": "61", "DOI": "10.1160/TH03-12-0741", "volume": "92", "author": "LE Visser", "year": "2004", "unstructured": "Visser LE, van Schaik RH, van Vliet M, Trienekens PH, De Smet PA, Vulto AG et al. The risk of bleeding complications in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon. Thromb Haemost 2004; 92: 61\u201366.", "journal-title": "Thromb Haemost"}, {"key": "BF6500462_CR66", "doi-asserted-by": "publisher", "first-page": "19", "DOI": "10.1097/00008571-200401000-00002", "volume": "14", "author": "J Kirchheiner", "year": "2004", "unstructured": "Kirchheiner J, Ufer M, Walter EC, Kammerer B, Kahlich R, Meisel C et al. Effects of CYP2C9 polymorphisms on the pharmacokinetics of R- and S-phenprocoumon in healthy volunteers. Pharmacogenetics 2004; 14: 19\u201326.", "journal-title": "Pharmacogenetics"}, {"key": "BF6500462_CR67", "doi-asserted-by": "publisher", "first-page": "213", "DOI": "10.1007/s00228-003-0580-8", "volume": "59", "author": "E Hummers-Pradier", "year": "2003", "unstructured": "Hummers-Pradier E, Hess S, Adham IM, Papke T, Pieske B, Kochen MM . Determination of bleeding risk using genetic markers in patients taking phenprocoumon. Eur J Clin Pharmacol 2003; 59: 213\u2013219.", "journal-title": "Eur J Clin Pharmacol"}, {"key": "BF6500462_CR68", "doi-asserted-by": "publisher", "first-page": "409", "DOI": "10.1016/j.clpt.2004.08.006", "volume": "76", "author": "T Schalekamp", "year": "2004", "unstructured": "Schalekamp T, Oosterhof M, van Meegen E, van Der Meer FJ, Conemans J, Hermans M et al. Effects of cytochrome P450 2C9 polymorphisms on phenprocoumon anticoagulation status. Clin Pharmacol Ther 2004; 76: 409\u2013417.", "journal-title": "Clin Pharmacol Ther"}, {"key": "BF6500462_CR69", "doi-asserted-by": "publisher", "first-page": "2329", "DOI": "10.1182/blood-2005-03-1108", "volume": "106", "author": "EA Sconce", "year": "2005", "unstructured": "Sconce EA, Khan TI, Wynne HA, Avery P, Monkhouse L, King BP et al. The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen. Blood 2005; 106: 2329\u20132333.", "journal-title": "Blood"}, {"key": "BF6500462_CR70", "doi-asserted-by": "publisher", "first-page": "185", "DOI": "10.1038/sj.clpt.6100036", "volume": "81", "author": "T Schalekamp", "year": "2007", "unstructured": "Schalekamp T, Brasse BP, Roijers JF, van Meegen E, van der Meer FJ, van Wijk EM et al. VKORC1 and CYP2C9 genotypes and phenprocoumon anticoagulation status: interaction between both genotypes affects dose requirement. Clin Pharmacol Ther 2007; 81: 185\u2013193.", "journal-title": "Clin Pharmacol Ther"}, {"key": "BF6500462_CR71", "doi-asserted-by": "publisher", "first-page": "183", "DOI": "10.1111/j.1365-2141.2006.06007.x", "volume": "133", "author": "R Montes", "year": "2006", "unstructured": "Montes R, Ruiz de Gaona E, Martinez-Gonzalez MA, Alberca I, Hermida J . The c.\u22121639G&gt;A polymorphism of the VKORC1 gene is a major determinant of the response to acenocoumarol in anticoagulated patients. Br J Haematol 2006; 133: 183\u2013187.", "journal-title": "Br J Haematol"}, {"key": "BF6500462_CR72", "first-page": "594", "volume": "46", "author": "SM De Morais", "year": "1994", "unstructured": "De Morais SM, Wilkinson GR, Blaisdell J, Meyer UA, Nakamura K, Goldstein JA . Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese. Mol Pharmacol 1994; 46: 594\u2013598.", "journal-title": "Mol Pharmacol"}, {"key": "BF6500462_CR73", "doi-asserted-by": "publisher", "first-page": "369", "DOI": "10.1046/j.1365-2125.1998.t01-1-00702.x", "volume": "45", "author": "T Andersson", "year": "1998", "unstructured": "Andersson T, Holmberg J, Rohss K, Walan A . Pharmacokinetics and effect on caffeine metabolism of the proton pump inhibitors, omeprazole, lansoprazole, and pantoprazole. Br J Clin Pharmacol 1998; 45: 369\u2013375.", "journal-title": "Br J Clin Pharmacol"}, {"key": "BF6500462_CR74", "doi-asserted-by": "publisher", "first-page": "2", "DOI": "10.1111/j.1600-0773.2004.pto950102.x", "volume": "95", "author": "U Klotz", "year": "2004", "unstructured": "Klotz U, Schwab M, Treiber G . CYP2C19 polymorphism and proton pump inhibitors. Basic Clin Pharmacol Toxicol 2004; 95: 2\u20138.", "journal-title": "Basic Clin Pharmacol Toxicol"}, {"key": "BF6500462_CR75", "doi-asserted-by": "publisher", "first-page": "460", "DOI": "10.1592/phco.23.4.460.32128", "volume": "23", "author": "E Chong", "year": "2003", "unstructured": "Chong E, Ensom MH . Pharmacogenetics of the proton pump inhibitors: a systematic review. Pharmacotherapy 2003; 23: 460\u2013471.", "journal-title": "Pharmacotherapy"}, {"key": "BF6500462_CR76", "first-page": "595", "volume": "57", "author": "U Fuhr", "year": "2002", "unstructured": "Fuhr U, Jetter A . Rabeprazole: pharmacokinetics and pharmacokinetic drug interactions. Pharmazie 2002; 57: 595\u2013601.", "journal-title": "Pharmazie"}, {"key": "BF6500462_CR77", "doi-asserted-by": "publisher", "first-page": "341", "DOI": "10.1097/00008571-200106000-00009", "volume": "11", "author": "T Furuta", "year": "2001", "unstructured": "Furuta T, Shirai N, Takashima M, Xiao F, Hanai H, Nakagawa K et al. Effects of genotypic differences in CYP2C19 status on cure rates for Helicobacter pylori infection by dual therapy with rabeprazole plus amoxicillin. Pharmacogenetics 2001; 11: 341\u2013348.", "journal-title": "Pharmacogenetics"}, {"key": "BF6500462_CR78", "doi-asserted-by": "publisher", "first-page": "158", "DOI": "10.1067/mcp.2001.113959", "volume": "69", "author": "T Furuta", "year": "2001", "unstructured": "Furuta T, Shirai N, Takashima M, Xiao F, Hanai H, Sugimura H et al. Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin. Clin Pharmacol Ther 2001; 69: 158\u2013168.", "journal-title": "Clin Pharmacol Ther"}, {"key": "BF6500462_CR79", "doi-asserted-by": "publisher", "first-page": "1027", "DOI": "10.7326/0003-4819-129-12-199812150-00006", "volume": "129", "author": "T Furuta", "year": "1998", "unstructured": "Furuta T, Ohashi K, Kamata T, Takashima M, Kosuge K, Kawasaki T et al. Effect of genetic differences in omeprazole metabolism on cure rates for Helicobacter pylori infection and peptic ulcer. Ann Intern Med 1998; 129: 1027\u20131030.", "journal-title": "Ann Intern Med"}, {"key": "BF6500462_CR80", "doi-asserted-by": "publisher", "first-page": "181", "DOI": "10.1517/phgs.5.2.181.27483", "volume": "5", "author": "T Furuta", "year": "2004", "unstructured": "Furuta T, Shirai N, Sugimoto M, Ohashi K, Ishizaki T . Pharmacogenomics of proton pump inhibitors. Pharmacogenomics 2004; 5: 181\u2013202.", "journal-title": "Pharmacogenomics"}, {"key": "BF6500462_CR81", "doi-asserted-by": "publisher", "first-page": "174", "DOI": "10.1159/000028398", "volume": "61", "author": "PJ Wedlund", "year": "2000", "unstructured": "Wedlund PJ . The CYP2C19 enzyme polymorphism. Pharmacology 2000; 61: 174\u2013183.", "journal-title": "Pharmacology"}, {"key": "BF6500462_CR82", "doi-asserted-by": "publisher", "first-page": "201", "DOI": "10.1016/j.clpt.2004.05.002", "volume": "76", "author": "M Schwab", "year": "2004", "unstructured": "Schwab M, Schaeffeler E, Klotz U, Treiber G . CYP2C19 polymorphism is a major predictor of treatment failure in white patients by use of lansoprazole-based quadruple therapy for eradication of Helicobacter pylori. Clin Pharmacol Ther 2004; 76: 201\u2013209.", "journal-title": "Clin Pharmacol Ther"}, {"key": "BF6500462_CR83", "doi-asserted-by": "publisher", "first-page": "1467", "DOI": "10.1111/j.1572-0241.2006.00717.x", "volume": "101", "author": "S Padol", "year": "2006", "unstructured": "Padol S, Yuan Y, Thabane M, Padol IT, Hunt RH . The effect of CYP2C19 polymorphisms on H. pylori eradication rate in dual and triple first-line PPI therapies: a meta-analysis. Am J Gastroenterol 2006; 101: 1467\u20131475.", "journal-title": "Am J Gastroenterol"}, {"key": "BF6500462_CR84", "doi-asserted-by": "publisher", "first-page": "573", "DOI": "10.1515/CCLM.2003.087", "volume": "41", "author": "M Oscarson", "year": "2003", "unstructured": "Oscarson M . Pharmacogenetics of drug metabolising enzymes: importance for personalised medicine. Clin Chem Lab Med 2003; 41: 573\u2013580.", "journal-title": "Clin Chem Lab Med"}, {"key": "BF6500462_CR85", "doi-asserted-by": "publisher", "first-page": "37", "DOI": "10.1097/00008571-199902000-00006", "volume": "9", "author": "ES Collie-Duguid", "year": "1999", "unstructured": "Collie-Duguid ES, Pritchard SC, Powrie RH, Sludden J, Collier DA, Li T et al. The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations. Pharmacogenetics 1999; 9: 37\u201342.", "journal-title": "Pharmacogenetics"}, {"key": "BF6500462_CR86", "first-page": "651", "volume": "32", "author": "RM Weinshilboum", "year": "1980", "unstructured": "Weinshilboum RM, Sladek SL . Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet 1980; 32: 651\u2013662.", "journal-title": "Am J Hum Genet"}, {"key": "BF6500462_CR87", "doi-asserted-by": "publisher", "first-page": "2293", "DOI": "10.1200/JCO.2001.19.8.2293", "volume": "19", "author": "WE Evans", "year": "2001", "unstructured": "Evans WE, Hon YY, Bomgaars L, Coutre S, Holdsworth M, Janco R et al. Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine. J Clin Oncol 2001; 19: 2293\u20132301.", "journal-title": "J Clin Oncol"}, {"key": "BF6500462_CR88", "doi-asserted-by": "publisher", "first-page": "18", "DOI": "10.1038/clpt.1987.4", "volume": "41", "author": "L Lennard", "year": "1987", "unstructured": "Lennard L, Van Loon JA, Lilleyman JS, Weinshilboum RM . Thiopurine pharmacogenetics in leukemia: correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations. Clin Pharmacol Ther 1987; 41: 18\u201325.", "journal-title": "Clin Pharmacol Ther"}, {"key": "BF6500462_CR89", "doi-asserted-by": "publisher", "first-page": "696", "DOI": "10.1046/j.1365-2141.1999.01416.x", "volume": "105", "author": "HL McLeod", "year": "1999", "unstructured": "McLeod HL, Coulthard S, Thomas AE, Pritchard SC, King DJ, Richards SM et al. Analysis of thiopurine methyltransferase variant alleles in childhood acute lymphoblastic leukaemia. Br J Haematol 1999; 105: 696\u2013700.", "journal-title": "Br J Haematol"}, {"key": "BF6500462_CR90", "doi-asserted-by": "publisher", "first-page": "608", "DOI": "10.7326/0003-4819-126-8-199704150-00003", "volume": "126", "author": "CR Yates", "year": "1997", "unstructured": "Yates CR, Krynetski EY, Loennechen T, Fessing MY, Tai HL, Pui CH et al. Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Ann Intern Med 1997; 126: 608\u2013614.", "journal-title": "Ann Intern Med"}, {"key": "BF6500462_CR91", "doi-asserted-by": "publisher", "first-page": "436", "DOI": "10.1016/0140-6736(93)93028-Y", "volume": "341", "author": "E Schutz", "year": "1993", "unstructured": "Schutz E, Gummert J, Mohr F, Oellerich M . Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipient. Lancet 1993; 341: 436.", "journal-title": "Lancet"}, {"key": "BF6500462_CR92", "doi-asserted-by": "publisher", "first-page": "437", "DOI": "10.1146/annurev.med.54.101601.152352", "volume": "54", "author": "R Nagasubramanian", "year": "2003", "unstructured": "Nagasubramanian R, Innocenti F, Ratain MJ . Pharmacogenetics in cancer treatment. Annu Rev Med 2003; 54: 437\u2013452.", "journal-title": "Annu Rev Med"}, {"key": "BF6500462_CR93", "doi-asserted-by": "publisher", "first-page": "1025", "DOI": "10.1016/S0016-5085(00)70354-4", "volume": "118", "author": "JF Colombel", "year": "2000", "unstructured": "Colombel JF, Ferrari N, Debuysere H, Marteau P, Gendre JP, Bonaz B et al. Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy. Gastroenterology 2000; 118: 1025\u20131030.", "journal-title": "Gastroenterology"}, {"key": "BF6500462_CR94", "doi-asserted-by": "publisher", "first-page": "265", "DOI": "10.1007/s002280050457", "volume": "54", "author": "T Kroplin", "year": "1998", "unstructured": "Kroplin T, Weyer N, Gutsche S, Iven H . Thiopurine S-methyltransferase activity in human erythrocytes: a new HPLC method using 6-thioguanine as substrate. Eur J Clin Pharmacol 1998; 54: 265\u2013271.", "journal-title": "Eur J Clin Pharmacol"}, {"key": "BF6500462_CR95", "doi-asserted-by": "publisher", "first-page": "498", "DOI": "10.1053/gast.2001.26927", "volume": "121", "author": "M Schwab", "year": "2001", "unstructured": "Schwab M, Schaeffeler E, Marx C, Zanger U, Aulitzky W, Eichelbaum M . Shortcoming in the diagnosis of TPMT deficiency in a patient with Crohn's disease using phenotyping only. Gastroenterology 2001; 121: 498\u2013499.", "journal-title": "Gastroenterology"}, {"key": "BF6500462_CR96", "doi-asserted-by": "publisher", "first-page": "131", "DOI": "10.1046/j.1365-2125.1999.00884.x", "volume": "47", "author": "L Lennard", "year": "1999", "unstructured": "Lennard L . Therapeutic drug monitoring of antimetabolic cytotoxic drugs. Br J Clin Pharmacol 1999; 47: 131\u2013143.", "journal-title": "Br J Clin Pharmacol"}, {"key": "BF6500462_CR97", "doi-asserted-by": "publisher", "first-page": "356", "DOI": "10.1038/clpt.1980.174", "volume": "28", "author": "PA Pazmino", "year": "1980", "unstructured": "Pazmino PA, Sladek SL, Weinshilboum RM . Thiol S-methylation in uremia: erythrocyte enzyme activities and plasma inhibitors. Clin Pharmacol Ther 1980; 28: 356\u2013367.", "journal-title": "Clin Pharmacol Ther"}, {"key": "BF6500462_CR98", "doi-asserted-by": "publisher", "first-page": "108", "DOI": "10.1080/08035259850158001", "volume": "87", "author": "JB Andersen", "year": "1998", "unstructured": "Andersen JB, Szumlanski C, Weinshilboum RM, Schmiegelow K . Pharmacokinetics, dose adjustments, and 6-mercaptopurine/methotrexate drug interactions in two patients with thiopurine methyltransferase deficiency. Acta Paediatr 1998; 87: 108\u2013111.", "journal-title": "Acta Paediatr"}, {"key": "BF6500462_CR99", "doi-asserted-by": "publisher", "first-page": "186", "DOI": "10.1097/00007691-200404000-00018", "volume": "26", "author": "WE Evans", "year": "2004", "unstructured": "Evans WE . Pharmacogenetics of thiopurine S-methyltransferase and thiopurine therapy. Ther Drug Monit 2004; 26: 186\u2013191.", "journal-title": "Ther Drug Monit"}, {"key": "BF6500462_CR100", "author": "G Milan", "first-page": "289", "year": "1999", "unstructured": "Milan G, Etienne MC . 5-Fluorouracil. In: Grochow LB, Ames MM (Hrsg) (eds.). A Clinical Guide to Chemotherapy Pharmacokinetics and Pharmacodynamics. Williams & Wilkins: Baltimore, 1999 pp 289\u2013300.", "volume-title": "A Clinical Guide to Chemotherapy Pharmacokinetics and Pharmacodynamics"}, {"key": "BF6500462_CR101", "doi-asserted-by": "publisher", "first-page": "325", "DOI": "10.1016/S0165-6147(00)89065-3", "volume": "16", "author": "FJ Gonzalez", "year": "1995", "unstructured": "Gonzalez FJ, Fernandez-Salguero P . Diagnostic analysis, clinical importance and molecular basis of dihydropyrimidine dehydrogenase deficiency. Trends Pharmacol Sci 1995; 16: 325\u2013327.", "journal-title": "Trends Pharmacol Sci"}, {"key": "BF6500462_CR102", "doi-asserted-by": "publisher", "first-page": "610", "DOI": "10.1172/JCI118830", "volume": "98", "author": "X Wei", "year": "1996", "unstructured": "Wei X, McLeod HL, McMurrough J, Gonzalez FJ, Fernandez-Salguero P . Molecular basis of the human dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil toxicity. J Clin Invest 1996; 98: 610\u2013615.", "journal-title": "J Clin Invest"}, {"key": "BF6500462_CR103", "doi-asserted-by": "publisher", "first-page": "207", "DOI": "10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6", "volume": "47", "author": "AB Miller", "year": "1981", "unstructured": "Miller AB, Hoogstraten B, Staquet M, Winkler A . Reporting results of cancer treatment. Cancer 1981; 47: 207\u2013214.", "journal-title": "Cancer"}, {"key": "BF6500462_CR104", "doi-asserted-by": "publisher", "first-page": "797", "DOI": "10.1093/annonc/mdf035", "volume": "13", "author": "N Frickhofen", "year": "2002", "unstructured": "Frickhofen N, Beck FJ, Jung B, Fuhr HG, Andrasch H, Sigmund M . Capecitabine can induce acute coronary syndrome similar to 5-fluorouracil. Ann Oncol 2002; 13: 797\u2013801.", "journal-title": "Ann Oncol"}, {"key": "BF6500462_CR105", "doi-asserted-by": "publisher", "first-page": "217", "DOI": "10.1097/00008571-200004000-00002", "volume": "10", "author": "ES Collie-Duguid", "year": "2000", "unstructured": "Collie-Duguid ES, Etienne MC, Milano G, McLeod HL . Known variant DPYD alleles do not explain DPD deficiency in cancer patients. Pharmacogenetics 2000; 10: 217\u2013223.", "journal-title": "Pharmacogenetics"}, {"key": "BF6500462_CR106", "first-page": "2899", "volume": "52", "author": "RA Fleming", "year": "1992", "unstructured": "Fleming RA, Milano G, Thyss A, Etienne MC, Renee N, Schneider M et al. Correlation between dihydropyrimidine dehydrogenase activity in peripheral mononuclear cells and systemic clearance of fluorouracil in cancer patients. Cancer Res 1992; 52: 2899\u20132902.", "journal-title": "Cancer Res"}, {"key": "BF6500462_CR107", "first-page": "9", "volume": "46", "author": "AB Van Kuilenburg", "year": "2000", "unstructured": "Van Kuilenburg AB, Van Lenthe H, Tromp A, Veltman PC, Van Gennip AH . Pitfalls in the diagnosis of patients with a partial dihydropyrimidine dehydrogenase deficiency. Clin Chem 2000; 46: 9\u201317.", "journal-title": "Clin Chem"}, {"key": "BF6500462_CR108", "first-page": "2832", "volume": "7", "author": "M Raida", "year": "2001", "unstructured": "Raida M, Schwabe W, Hausler P, Van Kuilenburg AB, Van Gennip AH, Behnke D et al. Prevalence of a common point mutation in the dihydropyrimidine dehydrogenase (DPD) gene within the 5\u2032-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)-related toxicity compared with controls. Clin Cancer Res 2001; 7: 2832\u20132839.", "journal-title": "Clin Cancer Res"}, {"key": "BF6500462_CR109", "doi-asserted-by": "publisher", "first-page": "341", "DOI": "10.1093/annonc/mdg056", "volume": "14", "author": "AB Van Kuilenburg", "year": "2003", "unstructured": "Van Kuilenburg AB, Baars JW, Meinsma R, Van Gennip AH . Lethal 5-fluorouracil toxicity associated with a novel mutation in the dihydropyrimidine dehydrogenase gene. Ann Oncol 2003; 14: 341\u2013342.", "journal-title": "Ann Oncol"}, {"issue": "Suppl. 6", "key": "BF6500462_CR110", "first-page": "101", "volume": "25", "author": "C Kollmannsberger", "year": "2001", "unstructured": "Kollmannsberger C, Bokemeyer C, Marx C, Fischer J, Honecker F, Schwab M et al. The association between mutations in the dihydropyrimidine dehydrogenase gene and severe toxicity of the treatment with s-fluorouracil: a prospective multicenter study. Onkologie 2001; 25 (Suppl. 6): 101.", "journal-title": "Onkologie"}, {"key": "BF6500462_CR111", "first-page": "4705", "volume": "6", "author": "AB van Kuilenburg", "year": "2000", "unstructured": "van Kuilenburg AB, Haasjes J, Richel DJ, Zoetekouw L, Van Lenthe H, De Abreu RA et al. Clinical implications of dihydropyrimidine dehydrogenase (DPD) deficiency in patients with severe 5-fluorouracil-associated toxicity: identification of new mutations in the DPD gene. Clin Cancer Res 2000; 6: 4705\u20134712.", "journal-title": "Clin Cancer Res"}, {"key": "BF6500462_CR112", "doi-asserted-by": "publisher", "first-page": "501", "DOI": "10.1016/j.clpt.2004.01.010", "volume": "75", "author": "K Sai", "year": "2004", "unstructured": "Sai K, Saeki M, Saito Y, Ozawa S, Katori N, Jinno H et al. UGT1A1 haplotypes associated with reduced glucuronidation and increased serum bilirubin in irinotecan-administered Japanese patients with cancer. Clin Pharmacol Ther 2004; 75: 501\u2013515.", "journal-title": "Clin Pharmacol Ther"}, {"key": "BF6500462_CR113", "first-page": "596", "volume": "29", "author": "F Innocenti", "year": "2001", "unstructured": "Innocenti F, Iyer L, Ratain MJ . Pharmacogenetics of anticancer agents: lessons from amonafide and irinotecan. Drug Metab Dispos 2001; 29: 596\u2013600.", "journal-title": "Drug Metab Dispos"}, {"key": "BF6500462_CR114", "doi-asserted-by": "publisher", "first-page": "1255", "DOI": "10.1111/j.1349-7006.2006.00321.x", "volume": "97", "author": "K Araki", "year": "2006", "unstructured": "Araki K, Fujita K, Ando Y, Nagashima F, Yamamoto W, Endo H et al. Pharmacogenetic impact of polymorphisms in the coding region of the UGT1A1 gene on SN-38 glucuronidation in Japanese patients with cancer. Cancer Sci 2006; 97: 1255\u20131259.", "journal-title": "Cancer Sci"}, {"key": "BF6500462_CR115", "doi-asserted-by": "publisher", "first-page": "1382", "DOI": "10.1200/JCO.2004.07.173", "volume": "22", "author": "F Innocenti", "year": "2004", "unstructured": "Innocenti F, Undevia SD, Iyer L, Chen PX, Das S, Kocherginsky M et al. Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan. J Clin Oncol 2004; 22: 1382\u20131388.", "journal-title": "J Clin Oncol"}, {"key": "BF6500462_CR116", "first-page": "6921", "volume": "60", "author": "Y Ando", "year": "2000", "unstructured": "Ando Y, Saka H, Ando M, Sawa T, Muro K, Ueoka H et al. Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysis. Cancer Res 2000; 60: 6921\u20136926.", "journal-title": "Cancer Res"}, {"key": "BF6500462_CR117", "doi-asserted-by": "publisher", "first-page": "432", "DOI": "10.1016/j.tips.2006.06.007", "volume": "27", "author": "ML Maitland", "year": "2006", "unstructured": "Maitland ML, Vasisht K, Ratain MJ . TPMT, UGT1A1 and DPYD: genotyping to ensure safer cancer therapy? Trends Pharmacol Sci 2006; 27: 432\u2013437.", "journal-title": "Trends Pharmacol Sci"}, {"key": "BF6500462_CR118", "doi-asserted-by": "publisher", "first-page": "883", "DOI": "10.1053/jhep.2002.32102", "volume": "35", "author": "YS Huang", "year": "2002", "unstructured": "Huang YS, Chern HD, Su WJ, Wu JC, Lai SL, Yang SY et al. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis. Hepatology 2002; 35: 883\u2013889.", "journal-title": "Hepatology"}, {"key": "BF6500462_CR119", "doi-asserted-by": "publisher", "first-page": "846", "DOI": "10.1093/oxfordjournals.aje.a010289", "volume": "151", "author": "N Brockton", "year": "2000", "unstructured": "Brockton N, Little J, Sharp L, Cotton SC . N-acetyltransferase polymorphisms and colorectal cancer: a HuGE review. Am J Epidemiol 2000; 151: 846\u2013861.", "journal-title": "Am J Epidemiol"}, {"key": "BF6500462_CR120", "first-page": "1239", "volume": "10", "author": "S Garte", "year": "2001", "unstructured": "Garte S, Gaspari L, Alexandrie AK, Ambrosone C, Autrup H, Autrup JL et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev 2001; 10: 1239\u20131248.", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"key": "BF6500462_CR121", "doi-asserted-by": "publisher", "first-page": "204", "DOI": "10.1159/000028402", "volume": "61", "author": "DM Grant", "year": "2000", "unstructured": "Grant DM, Goodfellow GH, Sugamori KS, Durette K . Pharmacogentics of the human arylamine N-actyltransferases. Pharmacology 2000; 61: 204\u2013211.", "journal-title": "Pharmacology"}, {"key": "BF6500462_CR122", "first-page": "161", "volume": "57", "author": "H Tiitinen", "year": "1968", "unstructured": "Tiitinen H et al. Comparison of the isoniazid in activation in Finns and Lapps. Ann Med Int Finn 1968; 57: 161.", "journal-title": "Ann Med Int Finn"}, {"key": "BF6500462_CR123", "doi-asserted-by": "publisher", "first-page": "1717", "DOI": "10.1164/ajrccm.155.5.9154882", "volume": "155", "author": "DP Parkin", "year": "1997", "unstructured": "Parkin DP, Vandenplas S, Botha FJ, Vandenplas ML, Seifart HI, van Helden PD et al. Trimodality of isoniazid elimination: phenotype and genotype in patients with tuberculosis. Am J Respir Crit Care Med 1997; 155: 1717\u20131722.", "journal-title": "Am J Respir Crit Care Med"}, {"key": "BF6500462_CR124", "doi-asserted-by": "publisher", "first-page": "544", "DOI": "10.1248/bpb.24.544", "volume": "24", "author": "T Kita", "year": "2001", "unstructured": "Kita T, Tanigawara Y, Chikazawa S, Hatanaka H, Sakaeda T, Komada F et al. N-Acetyltransferase 2 genotype correlated with isoniazid acetylation in Japanese tuberculous patients. Biol Pharm Bull 2001; 24: 544\u2013549.", "journal-title": "Biol Pharm Bull"}, {"key": "BF6500462_CR125", "doi-asserted-by": "publisher", "first-page": "1733", "DOI": "10.1128/AAC.49.5.1733-1738.2005", "volume": "49", "author": "M Kinzig-Schippers", "year": "2005", "unstructured": "Kinzig-Schippers M, Tomalik-Scharte D, Jetter A, Scheidel B, Jakob V, Rodamer M et al. Should we use N-acetyltransferase type 2 genotyping to personalize isoniazid doses? Antimicrob Agents Chemother 2005; 49: 1733\u20131738.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "BF6500462_CR126", "doi-asserted-by": "publisher", "first-page": "342", "DOI": "10.2165/00003495-198529040-00003", "volume": "29", "author": "DWJ Clark", "year": "1985", "unstructured": "Clark DWJ . Genetically determine variability in acetylation and oxidation: therapeutic implications. Drugs 1985; 29: 342\u2013375.", "journal-title": "Drugs"}, {"key": "BF6500462_CR127", "first-page": "256", "volume": "4", "author": "M Ohno", "year": "2000", "unstructured": "Ohno M, Yamaguchi I, Yamamoto I, Fukuda T, Yokota S, Maekura R et al. Slow N-acetyltransferase 2 genotype affects the incidence of isoniazid and rifampicin-induced hepatotoxicity. Int J Tuberc Lung Dis 2000; 4: 256\u2013261.", "journal-title": "Int J Tuberc Lung Dis"}, {"key": "BF6500462_CR128", "doi-asserted-by": "publisher", "first-page": "883", "DOI": "10.1053/jhep.2002.32102", "volume": "35", "author": "YS Huang", "year": "2002", "unstructured": "Huang YS, Chern HD, Su WJ, Wu JC, Lai SL, Yang SY et al. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis. Hepatology 2002; 35: 883\u2013889.", "journal-title": "Hepatology"}, {"key": "BF6500462_CR129", "doi-asserted-by": "publisher", "first-page": "1425", "DOI": "10.1086/424999", "volume": "39", "author": "PR Donald", "year": "2004", "unstructured": "Donald PR, Sirgel FA, Venter A, Parkin DP, Seifart HI, van de Wal BW et al. The influence of human N-acetyltransferase genotype on the early bactericidal activity of isoniazid. Clin Infect Dis 2004; 39: 1425\u20131430.", "journal-title": "Clin Infect Dis"}, {"key": "BF6500462_CR130", "doi-asserted-by": "publisher", "first-page": "162", "DOI": "10.1038/sj.tpj.6500361", "volume": "6", "author": "W Kalow", "year": "2006", "unstructured": "Kalow W . Pharmacogenetics and pharmacogenomics: origin, status, and the hope for personalized medicine. Pharmacogenomics J 2006; 6: 162\u2013165.", "journal-title": "Pharmacogenomics J"}], "container-title": ["The Pharmacogenomics Journal"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/6500462.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/6500462", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/6500462.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 29]], "date-time": "2019-04-29T11:31:33Z", "timestamp": 1556537493000}, "score": 29.614328, "issued": {"date-parts": [[2007, 6, 5]]}, "references-count": 130, "journal-issue": {"published-print": {"date-parts": [[2008, 2]]}, "issue": "1"}, "alternative-id": ["BF6500462"], "URL": "http://dx.doi.org/10.1038/sj.tpj.6500462", "relation": {"cites": []}, "ISSN": ["1470-269X", "1473-1150"], "issn-type": [{"value": "1470-269X", "type": "print"}, {"value": "1473-1150", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T06:44:19Z", "timestamp": 1574491459959}, "reference-count": 76, "publisher": "Wiley", "issue": "2", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 1680, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2012, 4]]}, "DOI": "10.1111/j.1472-8206.2010.00917.x", "type": "journal-article", "created": {"date-parts": [[2011, 1, 26]], "date-time": "2011-01-26T03:48:38Z", "timestamp": 1296013718000}, "page": "295-306", "source": "Crossref", "is-referenced-by-count": 13, "title": ["Genetic polymorphisms of drug-metabolizing phase I enzymes CYP2E1, CYP2A6 and CYP3A5 in South Indian population"], "prefix": "10.1111", "volume": "26", "author": [{"given": "D.", "family": "Krishnakumar", "sequence": "first", "affiliation": []}, {"given": "Umamaheswaran", "family": "Gurusamy", "sequence": "additional", "affiliation": []}, {"given": "Kayathri", "family": "Dhandapani", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Surendiran", "sequence": "additional", "affiliation": []}, {"given": "Ruchi", "family": "Baghel", "sequence": "additional", "affiliation": []}, {"given": "Ritushree", "family": "Kukreti", "sequence": "additional", "affiliation": []}, {"given": "Reneega", "family": "Gangadhar", "sequence": "additional", "affiliation": []}, {"given": "Ushakiran", "family": "Prayaga", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Manjunath", "sequence": "additional", "affiliation": []}, {"given": "C.", "family": "Adithan", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2011, 1, 25]]}, "reference": [{"key": "10.1111/j.1472-8206.2010.00917.x-BIB1|cit1", "author": "Woolf", "year": "1999", "volume-title": "Handbook of drug metabolism", "DOI": "10.1201/b13995", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB2|cit2", "doi-asserted-by": "crossref", "first-page": "168", "DOI": "10.1021/tx00020a008", "article-title": "Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects", "volume": "4", "author": "Guengerich", "year": "1991", "journal-title": "Chem. Res. Toxicol."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB3|cit3", "first-page": "518", "article-title": "Dominant role of cytochrome P-450 2E1 in human hepatic microsomal oxidation of the CFC-substitute 1,1,1,2-tetrafluoroethane", "volume": "20", "author": "Surbrook", "year": "1992", "journal-title": "Drug Metab. Dispos."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB4|cit4", "doi-asserted-by": "crossref", "first-page": "566", "DOI": "10.1021/tx00018a012", "article-title": "Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1", "volume": "3", "author": "Peter", "year": "1990", "journal-title": "Chem. Res. Toxicol."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB5|cit5", "doi-asserted-by": "crossref", "first-page": "795", "DOI": "10.1097/00000542-199310000-00023", "article-title": "Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane", "volume": "79", "author": "Kharasch", "year": "1993", "journal-title": "Anesthesiology"}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB6|cit6", "doi-asserted-by": "crossref", "first-page": "792", "DOI": "10.3748/wjg.v7.i6.792", "article-title": "Cytochrome P450 2E1 genetic polymorphism and gastric cancer in Changle, Fujian Province", "volume": "7", "author": "Cai", "year": "2001", "journal-title": "World J. Gastroenterol."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB7|cit7", "doi-asserted-by": "crossref", "first-page": "19S", "DOI": "10.1111/j.1530-0277.2001.tb02412.x", "article-title": "Effect of ALDH2 and CYP2E1 gene polymorphisms on drinking behavior and alcoholic liver disease in Japanese male workers", "volume": "25", "author": "Okamoto", "year": "2001", "journal-title": "Alcohol. Clin. Exp. Res."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB8|cit8", "doi-asserted-by": "crossref", "first-page": "35", "DOI": "10.1016/S0304-3835(01)00686-3", "article-title": "CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people", "volume": "174", "author": "Quinones", "year": "2001", "journal-title": "Cancer Lett."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB9|cit9", "author": "Ronis", "first-page": "211", "year": "1996", "volume-title": "Pharmacological and toxicological aspects"}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB10|cit10", "doi-asserted-by": "crossref", "first-page": "211", "DOI": "10.1016/0003-9861(92)90115-D", "article-title": "Species differences and interindividual variation in liver microsomal cytochrome P450 2A enzymes: effects on coumarin, dicumarol, and testosterone oxidation", "volume": "298", "author": "Pearce", "year": "1992", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB11|cit11", "first-page": "1002", "article-title": "Stereoselective metabolism of a new anticonvulsant drug candidate, losigamone, by human liver microsomes", "volume": "24", "author": "Torchin", "year": "1996", "journal-title": "Drug Metab. Dispos."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB12|cit12", "first-page": "605", "article-title": "Human halothane reduction in-vitro by cytochrome P450 2A6 and 3A4: identification of low and high KM isoforms", "volume": "26", "author": "Spracklin", "year": "1998", "journal-title": "Drug Metab. Dispos."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB13|cit13", "doi-asserted-by": "crossref", "first-page": "853", "DOI": "10.1007/s002280050707", "article-title": "Human halothane metabolism, lipid peroxidation, and cytochromes P(450)2A6 and P(450)3A4", "volume": "55", "author": "Kharasch", "year": "2000", "journal-title": "Eur. J. Clin. Pharmacol."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB14|cit14", "doi-asserted-by": "crossref", "first-page": "639", "DOI": "10.1021/tx990015e", "article-title": "Characterization of multiple products of cytochrome P450 2A6-catalyzed cotinine metabolism", "volume": "12", "author": "Murphy", "year": "1999", "journal-title": "Chem. Res. Toxicol."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB15|cit15", "doi-asserted-by": "crossref", "first-page": "1789", "DOI": "10.1093/carcin/13.10.1789", "article-title": "Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes", "volume": "13", "author": "Yamazaki", "year": "1992", "journal-title": "Carcinogenesis"}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB16|cit16", "doi-asserted-by": "crossref", "first-page": "1690", "DOI": "10.1038/bjc.1997.287", "article-title": "The dose-response relationship between cigarette consumption, biochemical markers and risk of lung cancer", "volume": "75", "author": "Law", "year": "1997", "journal-title": "Br. J. Cancer"}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "658", "DOI": "10.1006/bbrc.1999.1089", "article-title": "CYP2A6 gene deletion reduces susceptibility to lung cancer", "volume": "261", "author": "Miyamoto", "year": "1999", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB18|cit18", "doi-asserted-by": "crossref", "first-page": "72", "DOI": "10.1067/mcp.2001.112688", "article-title": "Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans", "volume": "69", "author": "Nakajima", "year": "2001", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB19|cit19", "doi-asserted-by": "crossref", "first-page": "511", "DOI": "10.1046/j.1365-2125.2002.01667.x", "article-title": "Genetic polymorphisms in human CYP2A6 gene causing impaired nicotine metabolism", "volume": "54", "author": "Yoshida", "year": "2002", "journal-title": "Br. J. Clin. Pharmacol."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB20|cit20", "doi-asserted-by": "crossref", "first-page": "111", "DOI": "10.1097/00008571-200103000-00002", "article-title": "Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene", "volume": "11", "author": "Gellner", "year": "2001", "journal-title": "Pharmacogenetics"}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB21|cit21", "doi-asserted-by": "crossref", "first-page": "13", "DOI": "10.1016/S0378-1119(00)00470-4", "article-title": "The human cytochrome P450 3A locus. Gene evolution by capture of downstream exons", "volume": "260", "author": "Finta", "year": "2000", "journal-title": "Gene"}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB22|cit22", "doi-asserted-by": "crossref", "first-page": "389", "DOI": "10.1146/annurev.pharmtox.38.1.389", "article-title": "In-vitro and in-vivo drug interactions involving human CYP3A", "volume": "38", "author": "Thummel", "year": "1998", "journal-title": "Annu. Rev. Pharmacol. Toxicol."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB23|cit23", "doi-asserted-by": "crossref", "first-page": "773", "DOI": "10.1097/00008571-200112000-00005", "article-title": "The genetic determinants of the CYP3A5 polymorphism", "volume": "11", "author": "Hustert", "year": "2001", "journal-title": "Pharmacogenetics"}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB24|cit24", "doi-asserted-by": "crossref", "first-page": "383", "DOI": "10.1038/86882", "article-title": "Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression", "volume": "27", "author": "Kuehl", "year": "2001", "journal-title": "Nat. Genet."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB25|cit25", "doi-asserted-by": "crossref", "first-page": "489", "DOI": "10.1038/nature08365", "article-title": "Reconstructing Indian population history", "volume": "24", "author": "Reich", "year": "2009", "journal-title": "Nature"}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB26|cit26", "first-page": "1668", "article-title": "CYP3A5 variant allele frequencies in Dutch Caucasians", "volume": "48", "author": "Van Schaik", "year": "2002", "journal-title": "Clin. Chem."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB27|cit27", "doi-asserted-by": "crossref", "first-page": "105", "DOI": "10.1016/S0014-5793(99)00359-2", "article-title": "Characterisation and PCR-based detection of a CYP2A6 gene deletion found at a high frequency in a Chinese population", "volume": "448", "author": "Oscarson", "year": "1999", "journal-title": "FEBS Lett."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB28|cit28", "first-page": "315", "article-title": "Genetic polymorphisms of CYP2E1 and GSTP1 in a South Indian population-comparison with North Indians, Caucasians and Chinese", "volume": "6", "author": "Soya", "year": "2005", "journal-title": "Asian Pac. J. Cancer Prev."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB29|cit29", "doi-asserted-by": "crossref", "first-page": "2303", "DOI": "10.1093/nar/3.9.2303", "article-title": "A general method for isolation of high molecular weight DNA from eukaryotes", "volume": "3", "author": "Blin", "year": "1976", "journal-title": "Nucleic Acids Res."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB30|cit30", "first-page": "370", "article-title": "Genetic polymorphism of human CYP2E1: characterization of two variant alleles", "volume": "51", "author": "Hu", "year": "1997", "journal-title": "Mol. Pharmacol."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB31|cit31", "doi-asserted-by": "crossref", "first-page": "91", "DOI": "10.1097/00008571-199804000-00001", "article-title": "Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers", "volume": "8", "author": "Matthias", "year": "1998", "journal-title": "Pharmacogenetics"}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB32|cit32", "doi-asserted-by": "crossref", "first-page": "595", "DOI": "10.1016/0076-6879(91)06129-Q", "article-title": "Induction, purification, and characterization of cytochrome P450IIE", "volume": "206", "author": "Yang", "year": "1991", "journal-title": "Methods Enzymol"}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB33|cit33", "first-page": "5387", "article-title": "Benzene metabolism by ethanol-, acetone-, and benzene-inducible cytochrome P-450 (IIE1) in rat and rabbit liver microsomes", "volume": "48", "author": "Johansson", "year": "1988", "journal-title": "Cancer Res."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB34|cit34", "first-page": "13607", "article-title": "Identification of ethanol-inducible P-450 isozyme 3a as the acetone and acetol monooxygenase of rabbit microsomes", "volume": "260", "author": "Koop", "year": "1985", "journal-title": "J. Biol. Chem."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB35|cit35", "doi-asserted-by": "crossref", "first-page": "207", "DOI": "10.1016/0014-5793(93)80547-8", "article-title": "Genetic polymorphism of cytochrome P4502E1 in a Swedish population. Relationship to incidence of lung cancer", "volume": "319", "author": "Persson", "year": "1993", "journal-title": "FEBS Lett."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB36|cit36", "doi-asserted-by": "crossref", "first-page": "88", "DOI": "10.1136/mp.53.2.88", "article-title": "Genetic polymorphisms of cytochrome p4502E1 and susceptibility to alcoholic liver disease and hepatocellular carcinoma in a white population: a study and literature review, including meta-analysis", "volume": "53", "author": "Wong", "year": "2000", "journal-title": "Mol. Pathol."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB37|cit37", "first-page": "6", "article-title": "Genetic polymorphism of drug metabolizing enzymes (CYP2E1, GSTP1) and susceptibility to bladder cancer in North India", "volume": "6", "author": "Mittal", "year": "2005", "journal-title": "Asian Pac. J. Cancer Prev."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB38|cit38", "doi-asserted-by": "crossref", "first-page": "1207", "DOI": "10.1093/jnci/89.16.1207", "article-title": "CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan", "volume": "89", "author": "Hildesheim", "year": "1997", "journal-title": "J. Natl Cancer Inst."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB39|cit39", "doi-asserted-by": "crossref", "first-page": "967", "DOI": "10.1093/carcin/18.5.967", "article-title": "Associations between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer", "volume": "18", "author": "Wu", "year": "1997", "journal-title": "Carcinogenesis"}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB40|cit40", "doi-asserted-by": "crossref", "first-page": "325", "DOI": "10.1002/(SICI)1097-0215(19990505)81:3<325::AID-IJC2>3.0.CO;2-S", "article-title": "Genetic polymorphism of xenobiotic metabolising enzymes among Chinese lung cancer patients", "volume": "81", "author": "Persson", "year": "1999", "journal-title": "Int. J. Cancer"}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB41|cit41", "first-page": "583", "article-title": "Cytochrome P450 2E1 polymorphism as a risk factor for lung cancer in relation to P53 gene mutation", "volume": "17", "author": "Oyama", "year": "1997", "journal-title": "Anticancer Res."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB42|cit42", "doi-asserted-by": "crossref", "first-page": "58", "DOI": "10.1097/00008571-199404000-00002", "article-title": "Restriction fragment length polymorphism of the human CYP2E1 (cytochrome P450IIE1) gene and susceptibility to lung cancer: possible relevance to low smoking exposure", "volume": "4", "author": "Uematsun", "year": "1994", "journal-title": "Pharmacogenetics"}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB43|cit43", "first-page": "1212", "article-title": "Role of human cytochrome P4502A6 in C-oxidation of nicotine", "volume": "24", "author": "Nakajima", "year": "1996", "journal-title": "Drug Metab. Dispos."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB44|cit44", "doi-asserted-by": "crossref", "first-page": "145", "DOI": "10.1016/j.clpt.2004.10.011", "article-title": "Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence", "volume": "77", "author": "Malaiyandi", "year": "2005", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB45|cit45", "doi-asserted-by": "crossref", "first-page": "419", "DOI": "10.1016/j.ejps.2004.04.012", "article-title": "Metabolic profile of nicotine in subjects whose CYP2A6 gene is deleted", "volume": "22", "author": "Yamanaka", "year": "2004", "journal-title": "Eur. J. Pharm. Sci."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB46|cit46", "doi-asserted-by": "crossref", "first-page": "317", "DOI": "10.1097/00008571-200106000-00006", "article-title": "Nicotine metabolism and CYP2A6 allele frequencies in Koreans", "volume": "11", "author": "Kwon", "year": "2001", "journal-title": "Pharmacogenetics"}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB47|cit47", "doi-asserted-by": "crossref", "first-page": "903", "DOI": "10.1016/S0278-6915(97)00066-5", "article-title": "A single amino acid substitution (Leu160His) in cytochrome P450 CYP2A6 causes switching from 7-hydroxylation to 3-hydroxylation of coumarin", "volume": "35", "author": "Hadidi", "year": "1997", "journal-title": "Food Chem. Toxicol."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB48|cit48", "doi-asserted-by": "crossref", "first-page": "195", "DOI": "10.1590/S0100-879X2006000200005", "article-title": "CYP2A6 and CYP2E1 polymorphism in a Brazilian population living in Rio de Janeiro", "volume": "39", "author": "Rossini", "year": "2006", "journal-title": "Braz. J. Med. Biol. Res."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB49|cit49", "doi-asserted-by": "crossref", "first-page": "201", "DOI": "10.1016/S0014-5793(98)01297-6", "article-title": "Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C-oxidase", "volume": "438", "author": "Oscarson", "year": "1998", "journal-title": "FEBS Lett."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB50|cit50", "doi-asserted-by": "crossref", "first-page": "75", "DOI": "10.1016/j.febslet.2004.05.053", "article-title": "Novel human CYP2A6 alleles confound gene deletion analysis", "volume": "569", "author": "Nakajima", "year": "2004", "journal-title": "FEBS Lett."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB51|cit51", "doi-asserted-by": "crossref", "first-page": "321", "DOI": "10.1016/S0014-5793(99)01364-2", "article-title": "Identification and characterisation of novel polymorphisms in the CYP2A locus: implications for nicotine metabolism", "volume": "460", "author": "Oscarson", "year": "1999", "journal-title": "FEBS Lett."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB52|cit52", "doi-asserted-by": "crossref", "first-page": "417", "DOI": "10.1007/s00228-002-0499-5", "article-title": "Allele and genotype frequencies of CYP2B6 and CYP3A5 in the Japanese population", "volume": "58", "author": "Hiratsuka", "year": "2002", "journal-title": "Eur. J. Clin. Pharmacol."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB53|cit53", "first-page": "414", "article-title": "Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians", "volume": "270", "author": "Shimada", "year": "1994", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB54|cit54", "doi-asserted-by": "crossref", "first-page": "461", "DOI": "10.1007/BF02353474", "article-title": "The human drug metabolizing cytochromes P450", "volume": "24", "author": "Wrighton", "year": "1996", "journal-title": "J. Pharmacokinet. Biopharm."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB55|cit55", "doi-asserted-by": "crossref", "first-page": "123", "DOI": "10.1007/s00228-003-0594-2", "article-title": "CYP3A5*3 and *6 single nucleotide polymorphisms in three distinct Asian populations", "volume": "59", "author": "Balram", "year": "2003", "journal-title": "Eur. J. Clin. Pharmacol."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB56|cit56", "first-page": "721", "article-title": "Optimization of initial tacrolimus dose using pharmacogenetic testing", "volume": "87", "author": "Thervet", "year": "2010", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB57|cit57", "doi-asserted-by": "crossref", "first-page": "331", "DOI": "10.1097/00008571-200206000-00009", "article-title": "Novel detection assay by PCR-RFLP and frequency of the CYP3A5*3 and *6 in a Japanese population", "volume": "12", "author": "Fukuen", "year": "2002", "journal-title": "Pharmacogenetics"}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB58|cit58", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1186/1471-2350-6-19", "article-title": "CYP3A4 and CYP3A5 genotyping by pyrosequencing", "volume": "6", "author": "Garsa", "year": "2005", "journal-title": "BMC Med. Genet."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB59|cit59", "first-page": "181", "article-title": "Association of CYP3A5*3 and CYP3A5*6 polymorphisms with breast cancer risk", "volume": "3", "author": "Surekha", "year": "2009", "journal-title": "Curr. Tren. Biotechnol. Pharm."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB60|cit60", "doi-asserted-by": "crossref", "first-page": "584", "DOI": "10.1016/S0140-6736(77)91430-1", "article-title": "Polymorphic hydroxylation of debrisoquine in man", "volume": "2", "author": "Mahgoub", "year": "1977", "journal-title": "Lancet"}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB61|cit61", "doi-asserted-by": "crossref", "first-page": "183", "DOI": "10.1007/BF00562059", "article-title": "Defective N-oxidation of sparteine in man: a new pharmacogenetic defect", "volume": "16", "author": "Eichelbaum", "year": "1979", "journal-title": "Eur. J. Clin. Pharmacol."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB62|cit62", "doi-asserted-by": "crossref", "first-page": "444", "DOI": "10.1016/S0009-9236(98)90040-6", "article-title": "10-Hydroxylation of nortriptyline in white persons with 0, 1, 2, 3, and 13 functional CYP2D6 genes", "volume": "63", "author": "Dalen", "year": "1998", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB63|cit63", "doi-asserted-by": "crossref", "first-page": "27", "DOI": "10.1038/clpt.1990.4", "article-title": "Polymorphic formation of morphine from codeine in poor and extensive metabolizers of dextromethorphan: relationship to the presence of immunoidentified cytochrome P-450IID1", "volume": "47", "author": "Mortimer", "year": "1990", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB64|cit64", "author": "Flockhart", "year": "2007", "volume-title": "Drug interactions: cytochrome P450 drug interaction table"}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB65|cit65", "doi-asserted-by": "crossref", "first-page": "717", "DOI": "10.1016/S0140-6736(98)04474-2", "article-title": "Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications", "volume": "353", "author": "Aithal", "year": "1999", "journal-title": "Lancet"}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB66|cit66", "doi-asserted-by": "crossref", "first-page": "287", "DOI": "10.1097/00008571-200106000-00002", "article-title": "The effect of genetic polymorphism of cytochrome P450 CYP2C9 on phenytoin dose requirement", "volume": "11", "author": "van der Weide", "year": "2001", "journal-title": "Pharmacogenetics"}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB67|cit67", "doi-asserted-by": "crossref", "first-page": "485", "DOI": "10.1136/bmj.2.5197.485", "article-title": "Genetic control of isoniazid metabolism in man", "volume": "2", "author": "Price Evans", "year": "1960", "journal-title": "BMJ"}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB68|cit68", "doi-asserted-by": "crossref", "first-page": "350", "DOI": "10.1038/clpt.1980.173", "article-title": "Polymorphic acetylation of hydralazine", "volume": "28", "author": "Timbrell", "year": "1980", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB69|cit69", "doi-asserted-by": "crossref", "first-page": "722", "DOI": "10.1002/cpt1975176722", "article-title": "Polymorphic acetylation of procainamide in man", "volume": "17", "author": "Reidenberg", "year": "1975", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB70|cit70", "doi-asserted-by": "crossref", "first-page": "576", "DOI": "10.1016/S0009-9236(99)70078-0", "article-title": "Phenotype-genotype correlation of in vitro SN-38 (active metabolite of irinotecan) and bilirubin glucuronidation in human liver tissue with UGT1A1 promoter polymorphism", "volume": "65", "author": "Iyer", "year": "1999", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB71|cit71", "doi-asserted-by": "crossref", "first-page": "1171", "DOI": "10.1056/NEJM199511023331802", "article-title": "The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert\u2019s syndrome", "volume": "333", "author": "Bosma", "year": "1995", "journal-title": "N. Engl. J. Med."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB72|cit72", "doi-asserted-by": "crossref", "first-page": "19", "DOI": "10.1146/annurev.pharmtox.39.1.19", "article-title": "Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase", "volume": "39", "author": "Weinshilboum", "year": "1999", "journal-title": "Annu. Rev. Pharmacol. Toxicol."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB73|cit73", "doi-asserted-by": "crossref", "first-page": "597", "DOI": "10.2217/14622416.9.5.597", "article-title": "Pharmacogenetics of OATP (SLC21/SLCO), OAT and OCT (SLC22) and PEPT (SLC15) transporters in the intestine, liver and kidney", "volume": "9", "author": "Za\u00efr", "year": "2008", "journal-title": "Pharmacogenomics"}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB74|cit74", "doi-asserted-by": "crossref", "first-page": "1295", "DOI": "10.1093/jnci/92.16.1295", "article-title": "A family of drug transporters: the multidrug resistance-associated proteins", "volume": "92", "author": "Borst", "year": "2000", "journal-title": "J. Natl Cancer Inst."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB75|cit75", "first-page": "655", "article-title": "Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes", "volume": "28", "author": "Choo", "year": "2000", "journal-title": "Drug Metab. Dispos."}, {"key": "10.1111/j.1472-8206.2010.00917.x-BIB76|cit76", "doi-asserted-by": "crossref", "first-page": "835", "DOI": "10.1016/S1359-6446(01)01892-X", "article-title": "Pharmacogenetics of the human drug-transporter gene MDR1: impact of polymorphisms on pharmacotherapy", "volume": "6", "author": "Brinkmann", "year": "2001", "journal-title": "Drug Discov. Today"}], "container-title": ["Fundamental & Clinical Pharmacology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1472-8206.2010.00917.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 19]], "date-time": "2017-06-19T18:59:03Z", "timestamp": 1497898743000}, "score": 29.509745, "subtitle": ["CYP2E1, CYP2A6 and CYP3A5 gene polymorphisms"], "issued": {"date-parts": [[2011, 1, 25]]}, "references-count": 76, "journal-issue": {"published-print": {"date-parts": [[2012, 4]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.1111/j.1472-8206.2010.00917.x", "relation": {"cites": []}, "ISSN": ["0767-3981"], "issn-type": [{"value": "0767-3981", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T08:20:18Z", "timestamp": 1574324418654}, "reference-count": 32, "publisher": "Mary Ann Liebert Inc", "issue": "11", "license": [{"URL": "http://www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121/", "start": {"date-parts": [[2007, 11, 1]], "date-time": "2007-11-01T00:00:00Z", "timestamp": 1193875200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["DNA and Cell Biology"], "published-print": {"date-parts": [[2007, 11]]}, "DOI": "10.1089/dna.2007.0630", "type": "journal-article", "created": {"date-parts": [[2007, 10, 5]], "date-time": "2007-10-05T13:41:45Z", "timestamp": 1191591705000}, "page": "791-798", "source": "Crossref", "is-referenced-by-count": 22, "title": ["Cytochrome P4501A1 and Microsomal Epoxide Hydrolase Gene Polymorphisms: Gene\u2013Environment Interaction and Risk of Prostate Cancer"], "prefix": "10.1089", "volume": "26", "author": [{"given": "Rama D.", "family": "Mittal", "sequence": "first", "affiliation": [{"name": "Department of Urology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India."}]}, {"given": "Dayashankar L.", "family": "Srivastava", "sequence": "additional", "affiliation": [{"name": "Department of Urology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India."}]}], "member": "278", "container-title": ["DNA and Cell Biology"], "language": "en", "link": [{"URL": "http://www.liebertpub.com/doi/pdf/10.1089/dna.2007.0630", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 6]], "date-time": "2018-08-06T20:15:24Z", "timestamp": 1533586524000}, "score": 29.25952, "issued": {"date-parts": [[2007, 11]]}, "references-count": 32, "journal-issue": {"published-print": {"date-parts": [[2007, 11]]}, "issue": "11"}, "alternative-id": ["10.1089/dna.2007.0630"], "URL": "http://dx.doi.org/10.1089/dna.2007.0630", "ISSN": ["1044-5498", "1557-7430"], "issn-type": [{"value": "1044-5498", "type": "print"}, {"value": "1557-7430", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T04:42:55Z", "timestamp": 1574829775291}, "reference-count": 0, "publisher": "Informa UK Limited", "license": [{"URL": "http://creativecommons.org/licenses/by-nc/3.0/", "start": {"date-parts": [[2017, 9, 1]], "date-time": "2017-09-01T00:00:00Z", "timestamp": 1504224000000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["CMAR"], "DOI": "10.2147/cmar.s142677", "type": "journal-article", "created": {"date-parts": [[2017, 9, 5]], "date-time": "2017-09-05T00:28:44Z", "timestamp": 1504571324000}, "page": "381-386", "source": "Crossref", "is-referenced-by-count": 6, "title": ["<em>SIRT1</em> gene polymorphisms and risk of lung cancer"], "prefix": "10.2147", "volume": "Volume 9", "author": [{"given": "Yanbo", "family": "Lv", "sequence": "first", "affiliation": []}, {"given": "Shuangyan", "family": "Lin", "sequence": "additional", "affiliation": []}, {"given": "Fang", "family": "Peng", "sequence": "additional", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2017, 9]]}, "container-title": ["Cancer Management and Research"], "language": "en", "link": [{"URL": "https://www.dovepress.com/getfile.php?fileID=38250", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://www.dovepress.com/getfile.php?fileID=38250", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 9, 5]], "date-time": "2017-09-05T00:28:45Z", "timestamp": 1504571325000}, "score": 29.251108, "issued": {"date-parts": [[2017, 9]]}, "references-count": 0, "URL": "http://dx.doi.org/10.2147/cmar.s142677", "ISSN": ["1179-1322"], "issn-type": [{"value": "1179-1322", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T17:21:00Z", "timestamp": 1574443260029}, "reference-count": 47, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2012, 4, 1]], "date-time": "2012-04-01T00:00:00Z", "timestamp": 1333238400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Epidemiology"], "published-print": {"date-parts": [[2012, 4]]}, "DOI": "10.1016/j.canep.2011.11.010", "type": "journal-article", "created": {"date-parts": [[2012, 1, 11]], "date-time": "2012-01-11T00:21:24Z", "timestamp": 1326241284000}, "page": "e95-e100", "source": "Crossref", "is-referenced-by-count": 16, "title": ["Polymorphisms in the folate-metabolizing genes MTR, MTRR, and CBS and breast cancer risk"], "prefix": "10.1016", "volume": "36", "author": [{"given": "Alexandra S.", "family": "Weiner", "sequence": "first", "affiliation": []}, {"given": "Uljana A.", "family": "Boyarskikh", "sequence": "additional", "affiliation": []}, {"given": "Elena N.", "family": "Voronina", "sequence": "additional", "affiliation": []}, {"given": "Inna A.", "family": "Selezneva", "sequence": "additional", "affiliation": []}, {"given": "Tatiana V.", "family": "Sinkina", "sequence": "additional", "affiliation": []}, {"given": "Alexandr F.", "family": "Lazarev", "sequence": "additional", "affiliation": []}, {"given": "Valentina D.", "family": "Petrova", "sequence": "additional", "affiliation": []}, {"given": "Maxim L.", "family": "Filipenko", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Cancer Epidemiology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S187778211100186X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S187778211100186X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 6, 22]], "date-time": "2019-06-22T09:25:25Z", "timestamp": 1561195525000}, "score": 29.037506, "issued": {"date-parts": [[2012, 4]]}, "references-count": 47, "journal-issue": {"published-print": {"date-parts": [[2012, 4]]}, "issue": "2"}, "alternative-id": ["S187778211100186X"], "URL": "http://dx.doi.org/10.1016/j.canep.2011.11.010", "ISSN": ["1877-7821"], "issn-type": [{"value": "1877-7821", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T05:49:16Z", "timestamp": 1574315356617}, "reference-count": 0, "publisher": "Ferrata Storti Foundation (Haematologica)", "issue": "10", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Haematologica"], "published-print": {"date-parts": [[2009, 10, 1]]}, "DOI": "10.3324/haematol.2009.008326", "type": "journal-article", "created": {"date-parts": [[2009, 8, 1]], "date-time": "2009-08-01T00:34:46Z", "timestamp": 1249086886000}, "page": "1391-1398", "source": "Crossref", "is-referenced-by-count": 52, "title": ["Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival"], "prefix": "10.3324", "volume": "94", "author": [{"given": "A.", "family": "Ongaro", "sequence": "first", "affiliation": []}, {"given": "M.", "family": "De Mattei", "sequence": "additional", "affiliation": []}, {"given": "M. G.", "family": "Della Porta", "sequence": "additional", "affiliation": []}, {"given": "G.", "family": "Rigolin", "sequence": "additional", "affiliation": []}, {"given": "C.", "family": "Ambrosio", "sequence": "additional", "affiliation": []}, {"given": "F.", "family": "Di Raimondo", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Pellati", "sequence": "additional", "affiliation": []}, {"given": "F. F.", "family": "Masieri", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Caruso", "sequence": "additional", "affiliation": []}, {"given": "L.", "family": "Catozzi", "sequence": "additional", "affiliation": []}, {"given": "D.", "family": "Gemmati", "sequence": "additional", "affiliation": []}], "member": "1856", "published-online": {"date-parts": [[2009, 7, 31]]}, "container-title": ["Haematologica"], "language": "en", "deposited": {"date-parts": [[2011, 8, 8]], "date-time": "2011-08-08T20:29:36Z", "timestamp": 1312835376000}, "score": 28.972532, "issued": {"date-parts": [[2009, 7, 31]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2009, 9, 30]]}, "published-print": {"date-parts": [[2009, 10, 1]]}, "issue": "10"}, "URL": "http://dx.doi.org/10.3324/haematol.2009.008326", "ISSN": ["0390-6078", "1592-8721"], "issn-type": [{"value": "0390-6078", "type": "print"}, {"value": "1592-8721", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T05:54:12Z", "timestamp": 1574315652403}, "reference-count": 31, "publisher": "Mary Ann Liebert Inc", "issue": "8", "license": [{"URL": "http://www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121/", "start": {"date-parts": [[2007, 8, 1]], "date-time": "2007-08-01T00:00:00Z", "timestamp": 1185926400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["DNA and Cell Biology"], "published-print": {"date-parts": [[2007, 8]]}, "DOI": "10.1089/dna.2007.0600", "type": "journal-article", "created": {"date-parts": [[2007, 8, 9]], "date-time": "2007-08-09T17:26:22Z", "timestamp": 1186680382000}, "page": "613-618", "source": "Crossref", "is-referenced-by-count": 32, "title": ["Genetic Polymorphisms of the Interleukin-18 Gene and Risk of Prostate Cancer"], "prefix": "10.1089", "volume": "26", "author": [{"given": "Yunguang", "family": "Liu", "sequence": "first", "affiliation": [{"name": "Department of Scientific Research, Youjiang Medical College for Nationalities, Baise, Guangxi, People's Republic of China."}, {"name": "Department of Pediatrics, The Affiliated Hospital of Youjiang Medical College for Nationalities, Baise, Guangxi, People's Republic of China."}]}, {"given": "Na", "family": "Lin", "sequence": "additional", "affiliation": [{"name": "Department of Pediatrics, The Affiliated Hospital of Youjiang Medical College for Nationalities, Baise, Guangxi, People's Republic of China."}]}, {"given": "Li", "family": "Huang", "sequence": "additional", "affiliation": [{"name": "Department of Immunology, West China School of Preclinical and Forensic Medicine, Sichuan University, Chengdu, Sichuan, People's Republic of China."}]}, {"given": "Qunqing", "family": "Xu", "sequence": "additional", "affiliation": [{"name": "Center of Scientific Laboratory, Youjiang Medical College for Nationalities, Baise, Guangxi, People's Republic of China."}]}, {"given": "Guangfu", "family": "Pang", "sequence": "additional", "affiliation": [{"name": "Center of Scientific Laboratory, Youjiang Medical College for Nationalities, Baise, Guangxi, People's Republic of China."}]}], "member": "278", "container-title": ["DNA and Cell Biology"], "language": "en", "link": [{"URL": "http://www.liebertpub.com/doi/pdf/10.1089/dna.2007.0600", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 6]], "date-time": "2018-08-06T20:16:10Z", "timestamp": 1533586570000}, "score": 28.710144, "issued": {"date-parts": [[2007, 8]]}, "references-count": 31, "journal-issue": {"published-print": {"date-parts": [[2007, 8]]}, "issue": "8"}, "alternative-id": ["10.1089/dna.2007.0600"], "URL": "http://dx.doi.org/10.1089/dna.2007.0600", "ISSN": ["1044-5498", "1557-7430"], "issn-type": [{"value": "1044-5498", "type": "print"}, {"value": "1557-7430", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T19:31:52Z", "timestamp": 1574278312902}, "reference-count": 102, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2009, 8, 1]], "date-time": "2009-08-01T00:00:00Z", "timestamp": 1249084800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Lung Cancer"], "published-print": {"date-parts": [[2009, 8]]}, "DOI": "10.1016/j.lungcan.2009.01.002", "type": "journal-article", "created": {"date-parts": [[2009, 2, 1]], "date-time": "2009-02-01T09:11:43Z", "timestamp": 1233479503000}, "page": "129-137", "source": "Crossref", "is-referenced-by-count": 45, "title": ["Dietary chemoprevention strategies for induction of phase II xenobiotic-metabolizing enzymes in lung carcinogenesis: A review"], "prefix": "10.1016", "volume": "65", "author": [{"given": "Xiang-Lin", "family": "Tan", "sequence": "first", "affiliation": []}, {"given": "Simon D.", "family": "Spivack", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Lung Cancer"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0169500209000038?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0169500209000038?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 5, 17]], "date-time": "2019-05-17T18:32:01Z", "timestamp": 1558117921000}, "score": 28.59231, "issued": {"date-parts": [[2009, 8]]}, "references-count": 102, "journal-issue": {"published-print": {"date-parts": [[2009, 8]]}, "issue": "2"}, "alternative-id": ["S0169500209000038"], "URL": "http://dx.doi.org/10.1016/j.lungcan.2009.01.002", "ISSN": ["0169-5002"], "issn-type": [{"value": "0169-5002", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T21:27:03Z", "timestamp": 1574285223533}, "reference-count": 16, "publisher": "Wiley", "issue": "3", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 4506, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2003, 5]]}, "DOI": "10.1002/jhet.5570400315", "type": "journal-article", "created": {"date-parts": [[2009, 3, 11]], "date-time": "2009-03-11T09:49:32Z", "timestamp": 1236764972000}, "page": "507-512", "source": "Crossref", "is-referenced-by-count": 2, "title": ["7-Methyl Trimethoprim Analogues as Inhibitors of the Folate Metabolizing Enzymes"], "prefix": "10.1002", "volume": "40", "author": [{"given": "Aleem", "family": "Gangjee", "sequence": "first", "affiliation": []}, {"given": "Xin", "family": "Lin", "sequence": "additional", "affiliation": []}, {"given": "Sherry F.", "family": "Queener", "sequence": "additional", "affiliation": []}], "member": "311", "reference": [{"key": "10.1002/jhet.5570400315-BIB1", "author": "Castellano", "volume": "266", "first-page": "820", "year": "1991", "journal-title": "J. Am. Med. Assoc.", "DOI": "10.1001/jama.1991.03470060082031", "doi-asserted-by": "crossref"}, {"key": "10.1002/jhet.5570400315-BIB2", "author": "Georgiev", "volume": "13", "first-page": "529", "year": "1993", "journal-title": "Med. Res. Rev.", "DOI": "10.1002/med.2610130503", "doi-asserted-by": "crossref"}, {"key": "10.1002/jhet.5570400315-BIB3", "author": "Bartlett", "volume": "4", "first-page": "137", "year": "1991", "journal-title": "Clin. Microbiol. Rev.", "DOI": "10.1128/CMR.4.2.137", "doi-asserted-by": "crossref"}, {"key": "10.1002/jhet.5570400315-BIB4", "author": "Settler", "volume": "101", "first-page": "451", "year": "1992", "journal-title": "Chest.", "DOI": "10.1378/chest.101.2.451", "doi-asserted-by": "crossref"}, {"key": "10.1002/jhet.5570400315-BIB5", "author": "Jules-Elysee", "volume": "112", "first-page": "750", "year": "1990", "journal-title": "Ann. Intern. Med.", "DOI": "10.7326/0003-4819-112-10-750", "doi-asserted-by": "crossref"}, {"key": "10.1002/jhet.5570400315-BIB6", "author": "Masur", "volume": "327", "first-page": "1853", "year": "1992", "journal-title": "N. Engl. J. Med.", "DOI": "10.1056/NEJM199212243272606", "doi-asserted-by": "crossref"}, {"key": "10.1002/jhet.5570400315-BIB7", "author": "Dannemann", "volume": "116", "first-page": "3343", "year": "1992", "journal-title": "Ann. Intern. Med.", "DOI": "10.7326/0003-4819-116-1-33", "doi-asserted-by": "crossref"}, {"key": "10.1002/jhet.5570400315-BIB8", "author": "Allegra", "volume": "165", "first-page": "926", "year": "1987", "journal-title": "J. Exp. Med.", "DOI": "10.1084/jem.165.3.926", "doi-asserted-by": "crossref"}, {"key": "10.1002/jhet.5570400315-BIB9", "author": "Allegra", "volume": "79", "first-page": "478", "year": "1987", "journal-title": "J. Clin. Invest.", "DOI": "10.1172/JCI112837", "doi-asserted-by": "crossref"}, {"key": "10.1002/jhet.5570400315-BIB10", "author": "Kovacs", "volume": "32", "first-page": "430", "year": "1988", "journal-title": "Antimicro. Agents Chemother.", "DOI": "10.1128/AAC.32.4.430", "doi-asserted-by": "crossref"}, {"key": "10.1002/jhet.5570400315-BIB11", "author": "Queener", "volume": "31", "first-page": "1323", "year": "1987", "journal-title": "Antimicrob. Agents Chemother.", "DOI": "10.1128/AAC.31.9.1323", "doi-asserted-by": "crossref"}, {"key": "10.1002/jhet.5570400315-BIB12", "author": "Allegra", "volume": "317", "first-page": "978", "year": "1989", "journal-title": "N. Engl. J. Med.", "DOI": "10.1056/NEJM198710153171602", "doi-asserted-by": "crossref"}, {"key": "10.1002/jhet.5570400315-BIB13", "author": "Gangjee", "volume": "40", "first-page": "470", "year": "1997", "journal-title": "J. Med. Chem.", "DOI": "10.1021/jm9606913", "doi-asserted-by": "crossref"}, {"key": "10.1002/jhet.5570400315-BIB14", "author": "Cody", "volume": "338", "first-page": "481", "year": "1993", "journal-title": "Adv. Exp. Med. Biol.", "DOI": "10.1007/978-1-4615-2960-6_97", "doi-asserted-by": "crossref"}, {"key": "10.1002/jhet.5570400315-BIB15", "author": "Champness", "volume": "2", "first-page": "915", "year": "1994", "journal-title": "Structure", "DOI": "10.1016/S0969-2126(94)00093-X", "doi-asserted-by": "crossref"}, {"key": "10.1002/jhet.5570400315-BIB16", "author": "Chan", "volume": "34", "first-page": "550", "year": "1991", "journal-title": "J. Med. Chem.", "DOI": "10.1021/jm00106a011", "doi-asserted-by": "crossref"}], "container-title": ["Journal of Heterocyclic Chemistry"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjhet.5570400315", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/jhet.5570400315", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 2, 18]], "date-time": "2019-02-18T09:12:57Z", "timestamp": 1550481177000}, "score": 28.52211, "issued": {"date-parts": [[2003, 5]]}, "references-count": 16, "journal-issue": {"published-print": {"date-parts": [[2003, 5]]}, "issue": "3"}, "URL": "http://dx.doi.org/10.1002/jhet.5570400315", "relation": {"cites": []}, "ISSN": ["0022-152X", "1943-5193"], "issn-type": [{"value": "0022-152X", "type": "print"}, {"value": "1943-5193", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T00:52:36Z", "timestamp": 1574124756192}, "reference-count": 0, "publisher": "Oxford University Press (OUP)", "issue": "9", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Carcinogenesis"], "DOI": "10.1093/carcin/bgh175", "type": "journal-article", "created": {"date-parts": [[2004, 5, 4]], "date-time": "2004-05-04T00:38:49Z", "timestamp": 1083631129000}, "page": "1639-1647", "source": "Crossref", "is-referenced-by-count": 59, "title": ["Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study"], "prefix": "10.1093", "volume": "25", "author": [{"given": "J.", "family": "Lin", "sequence": "first", "affiliation": []}], "member": "286", "published-online": {"date-parts": [[2004, 4, 1]]}, "container-title": ["Carcinogenesis"], "language": "en", "link": [{"URL": "http://academic.oup.com/carcin/article-pdf/25/9/1639/7511959/bgh175.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 8, 24]], "date-time": "2017-08-24T12:33:10Z", "timestamp": 1503577990000}, "score": 28.422009, "issued": {"date-parts": [[2004, 4, 1]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2004, 4, 1]]}, "issue": "9"}, "URL": "http://dx.doi.org/10.1093/carcin/bgh175", "ISSN": ["1460-2180"], "issn-type": [{"value": "1460-2180", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T10:31:07Z", "timestamp": 1574159467309}, "reference-count": 34, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2003, 1, 1]], "date-time": "2003-01-01T00:00:00Z", "timestamp": 1041379200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Detection and Prevention"], "published-print": {"date-parts": [[2003, 1]]}, "DOI": "10.1016/s0361-090x(03)00033-3", "type": "journal-article", "created": {"date-parts": [[2003, 4, 4]], "date-time": "2003-04-04T23:06:29Z", "timestamp": 1049497589000}, "page": "139-146", "source": "Crossref", "is-referenced-by-count": 44, "title": ["Associations between genetic polymorphisms of Phase I and II metabolizing enzymes, p53 and susceptibility to esophageal adenocarcinoma"], "prefix": "10.1016", "volume": "27", "author": [{"given": "A.G", "family": "Casson", "sequence": "first", "affiliation": []}, {"given": "Z", "family": "Zheng", "sequence": "additional", "affiliation": []}, {"given": "D", "family": "Chiasson", "sequence": "additional", "affiliation": []}, {"given": "K", "family": "MacDonald", "sequence": "additional", "affiliation": []}, {"given": "D.C", "family": "Riddell", "sequence": "additional", "affiliation": []}, {"given": "J.R", "family": "Guernsey", "sequence": "additional", "affiliation": []}, {"given": "D.L", "family": "Guernsey", "sequence": "additional", "affiliation": []}, {"given": "J", "family": "McLaughlin", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Cancer Detection and Prevention"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0361090X03000333?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0361090X03000333?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 3, 24]], "date-time": "2019-03-24T08:59:46Z", "timestamp": 1553417986000}, "score": 27.878532, "issued": {"date-parts": [[2003, 1]]}, "references-count": 34, "journal-issue": {"published-print": {"date-parts": [[2003, 1]]}, "issue": "2"}, "alternative-id": ["S0361090X03000333"], "URL": "http://dx.doi.org/10.1016/s0361-090x(03)00033-3", "ISSN": ["0361-090X"], "issn-type": [{"value": "0361-090X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T15:18:40Z", "timestamp": 1574867920175}, "reference-count": 28, "publisher": "Frontiers Media SA", "content-domain": {"domain": ["frontiersin.org"], "crossmark-restriction": true}, "short-container-title": ["Front. Physiol."], "DOI": "10.3389/fphys.2017.00975", "type": "journal-article", "created": {"date-parts": [[2017, 12, 1]], "date-time": "2017-12-01T10:35:01Z", "timestamp": 1512124501000}, "update-policy": "http://dx.doi.org/10.3389/crossmark-policy", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Genetic Association between Matrix Metalloproteinases Gene Polymorphisms and Risk of Prostate Cancer: A Meta-Analysis"], "prefix": "10.3389", "volume": "8", "author": [{"given": "Hong", "family": "Weng", "sequence": "first", "affiliation": []}, {"given": "Xian-Tao", "family": "Zeng", "sequence": "additional", "affiliation": []}, {"given": "Xing-Huan", "family": "Wang", "sequence": "additional", "affiliation": []}, {"given": "Tong-Zu", "family": "Liu", "sequence": "additional", "affiliation": []}, {"given": "Da-Lin", "family": "He", "sequence": "additional", "affiliation": []}], "member": "1965", "published-online": {"date-parts": [[2017, 12, 1]]}, "reference": [{"key": "B1", "doi-asserted-by": "publisher", "first-page": "546", "DOI": "10.1016/j.arcmed.2015.08.004", "article-title": "Genetic polymorphism of MMP2 Gene and susceptibility to prostate cancer", "volume": "46", "author": "Adabi", "year": "2015", "journal-title": "Arch. Med. Res."}, {"key": "B2", "doi-asserted-by": "publisher", "first-page": "312", "DOI": "10.1159/000109715", "article-title": "Role of MMP-1 1G/2G promoter gene polymorphism on the development of prostate cancer in the Turkish population", "volume": "79", "author": "Albayrak", "year": "2007", "journal-title": "Urol. Int."}, {"key": "B3", "doi-asserted-by": "publisher", "first-page": "115", "DOI": "10.3322/caac.21338", "article-title": "Cancer statistics in China, 2015", "volume": "66", "author": "Chen", "year": "2016", "journal-title": "CA Cancer J. Clin."}, {"key": "B4", "doi-asserted-by": "publisher", "first-page": "2320", "DOI": "10.1016/j.juro.2009.01.012", "article-title": "Genetic polymorphisms of matrix metalloproteinases: susceptibility and prognostic implications for prostate cancer", "volume": "181", "author": "dos Reis", "year": "2009", "journal-title": "J. Urol."}, {"key": "B5", "doi-asserted-by": "publisher", "first-page": "273", "DOI": "10.3322/canjclin.47.5.273", "article-title": "Epidemiology of prostate cancer", "volume": "47", "author": "Haas", "year": "1997", "journal-title": "CA Cancer J. Clin."}, {"key": "B6", "doi-asserted-by": "publisher", "first-page": "197", "DOI": "10.1038/nrurol.2014.42", "article-title": "Prostate cancer in Asian men", "volume": "11", "author": "Ito", "year": "2014", "journal-title": "Nat. Rev. Urol."}, {"key": "B7", "doi-asserted-by": "publisher", "first-page": "972", "DOI": "10.1158/1055-9965.EPI-07-2787", "article-title": "Polymorphisms in angiogenesis-related genes and prostate cancer", "volume": "17", "author": "Jacobs", "year": "2008", "journal-title": "Cancer Epidemiol. Biomark. Prev."}, {"key": "B8", "doi-asserted-by": "publisher", "first-page": "1356", "DOI": "10.1158/1055-9965.EPI-13-0889", "article-title": "Genetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studies", "volume": "23", "author": "Knipe", "year": "2014", "journal-title": "Cancer Epidemiol. Biomark. Prev."}, {"key": "B9", "doi-asserted-by": "publisher", "first-page": "457", "DOI": "10.1186/s12885-016-2535-3", "article-title": "COX-2 rs689466, rs5275, and rs20417 polymorphisms and risk of head and neck squamous cell carcinoma: a meta-analysis of adjusted and unadjusted data", "volume": "16", "author": "Leng", "year": "2016", "journal-title": "BMC Cancer"}, {"key": "B10", "doi-asserted-by": "publisher", "first-page": "1006", "DOI": "10.1016/j.jclinepi.2009.06.005", "article-title": "Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement", "volume": "62", "author": "Moher", "year": "2009", "journal-title": "J. Clin. Epidemiol."}, {"key": "B11", "doi-asserted-by": "publisher", "first-page": "290", "DOI": "10.1016/j.mam.2008.05.002", "article-title": "Progress in matrix metalloproteinase research", "volume": "29", "author": "Murphy", "year": "2008", "journal-title": "Mol. Aspects Med."}, {"key": "B12", "doi-asserted-by": "publisher", "first-page": "25", "DOI": "10.1016/j.mce.2011.07.007", "article-title": "Polymorphisms in androgen signaling pathway predisposing to prostate cancer", "volume": "360", "author": "Schleutker", "year": "2012", "journal-title": "Mol. Cell. Endocrinol."}, {"key": "B13", "doi-asserted-by": "publisher", "first-page": "103", "DOI": "10.1007/s11845-016-1492-9", "article-title": "The association between MMP2-1306 C > T (rs243865) polymorphism and risk of prostate cancer", "volume": "186", "author": "Shajarehpoor Salavati", "year": "2017", "journal-title": "Ir. J. Med. Sci"}, {"key": "B14", "doi-asserted-by": "publisher", "first-page": "7", "DOI": "10.3322/caac.21332", "article-title": "Cancer statistics, 2016", "volume": "66", "author": "Siegel", "year": "2016", "journal-title": "CA Cancer J. Clin."}, {"key": "B15", "doi-asserted-by": "publisher", "first-page": "446", "DOI": "10.1016/j.bbcan.2014.08.007", "article-title": "Genetic variation: effect on prostate cancer", "volume": "1846", "author": "Sissung", "year": "2014", "journal-title": "Biochim. Biophys. Acta"}, {"key": "B16", "doi-asserted-by": "publisher", "first-page": "117", "DOI": "10.1016/j.arcmed.2012.02.006", "article-title": "Association of promoter polymorphisms in MMP2 and TIMP2 with prostate cancer susceptibility in North India", "volume": "43", "author": "Srivastava", "year": "2012", "journal-title": "Arch. Med. Res."}, {"key": "B17", "doi-asserted-by": "publisher", "first-page": "1291", "DOI": "10.1002/sim.2010", "article-title": "A method for meta-analysis of molecular association studies", "volume": "24", "author": "Thakkinstian", "year": "2005", "journal-title": "Stat. Med."}, {"key": "B18", "doi-asserted-by": "publisher", "first-page": "87", "DOI": "10.3322/caac.21262", "article-title": "Global cancer statistics, 2012", "volume": "65", "author": "Torre", "year": "2015", "journal-title": "CA Cancer J. Clin."}, {"key": "B19", "doi-asserted-by": "publisher", "first-page": "493", "DOI": "10.3892/or_00000462", "article-title": "Clinical significance of a single nucleotide polymorphism and allelic imbalance of matrix metalloproteinase-1 promoter region in prostate cancer", "volume": "22", "author": "Tsuchiya", "year": "2009", "journal-title": "Oncol. Rep."}, {"key": "B20", "doi-asserted-by": "publisher", "first-page": "24812", "DOI": "10.1038/srep24812", "article-title": "Matrix metalloproteinase gene polymorphisms and periodontitis susceptibility: a meta-analysis involving 6,162 individuals", "volume": "6", "author": "Weng", "year": "2016", "journal-title": "Sci. Rep."}, {"key": "B21", "doi-asserted-by": "publisher", "first-page": "741972", "DOI": "10.1155/2015/741972", "article-title": "Association between Estrogen Receptor-alpha Gene XbaI and PvuII polymorphisms and periodontitis susceptibility: a meta-analysis", "volume": "2015", "author": "Weng", "year": "2015", "journal-title": "Dis. Markers"}, {"key": "B22", "doi-asserted-by": "publisher", "first-page": "1865", "DOI": "10.1097/01.ju.0000140159.94703.80", "article-title": "Bicalutamide 150 mg in addition to standard care in patients with localized or locally advanced prostate cancer: results from the second analysis of the early prostate cancer program at median followup of 5.4 years", "volume": "172", "author": "Wirth", "year": "2004", "journal-title": "J. Urol."}, {"key": "B23", "doi-asserted-by": "publisher", "first-page": "19", "DOI": "10.1002/jcp.20948", "article-title": "Regulation of matrix metalloproteinase gene expression", "volume": "211", "author": "Yan", "year": "2007", "journal-title": "J. Cell. Physiol."}, {"key": "B24", "doi-asserted-by": "publisher", "first-page": "e354", "DOI": "10.1902/jop.2014.140317", "article-title": "Association between interleukin-4 gene\u2212590 c/t,\u221233 c/t, and 70-base-pair polymorphisms and periodontitis susceptibility: a meta-analysis", "volume": "85", "author": "Yan", "year": "2014", "journal-title": "J. Periodontol."}, {"key": "B25", "doi-asserted-by": "publisher", "first-page": "839", "DOI": "10.3906/sag-1305-63", "article-title": "Polymorphisms in MMP-2 and TIMP-2 in Turkish patients with prostate cancer", "volume": "44", "author": "Yaykasli", "year": "2014", "journal-title": "Turk J. Med. Sci."}, {"key": "B26", "doi-asserted-by": "publisher", "first-page": "469", "DOI": "10.1186/1471-2407-14-469", "article-title": "Association between the TP53 codon 72 polymorphism and risk of oral squamous cell carcinoma in Asians: a meta-analysis", "volume": "14", "author": "Zeng", "year": "", "journal-title": "BMC Cancer"}, {"key": "B27", "doi-asserted-by": "publisher", "first-page": "6713", "DOI": "10.1007/s11033-014-3554-2", "article-title": "Meta-analysis of vitamin D receptor gene polymorphisms and benign prostatic hyperplasia risk", "volume": "41", "author": "Zeng", "year": "", "journal-title": "Mol. Biol. Rep."}, {"key": "B28", "doi-asserted-by": "publisher", "first-page": "2403", "DOI": "10.2147/OTT.S103901", "article-title": "Genetic association between interluekin-4 rs2243250 polymorphism and gastric cancer susceptibility: evidence based on a meta-analysis", "volume": "9", "author": "Zhang", "year": "2016", "journal-title": "Onco. Targets. Ther."}], "container-title": ["Frontiers in Physiology"], "link": [{"URL": "http://journal.frontiersin.org/article/10.3389/fphys.2017.00975/full", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 12, 1]], "date-time": "2017-12-01T10:35:02Z", "timestamp": 1512124502000}, "score": 27.810268, "issued": {"date-parts": [[2017, 12, 1]]}, "references-count": 28, "alternative-id": ["10.3389/fphys.2017.00975"], "URL": "http://dx.doi.org/10.3389/fphys.2017.00975", "relation": {"cites": []}, "ISSN": ["1664-042X"], "issn-type": [{"value": "1664-042X", "type": "electronic"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}